Oncology Overdrive

View Details

In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting. With insights from Benjamin P. Levy, MD, and top headlines from the conference, Meeting Mic is your on-the-go source for highlights, pearls, and perspectives across all specialties.

Benjamin P. Levy, MD, discusses key takeaways from the meeting. 0:49

Read the full coverage here:

Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’

Source: Zhou C, et al. Abstract 2700. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego.

Perioperative nivolumab improves outcomes in resectable NSCLC

Source: Forde PM, et al. Abstract 3589. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego.

Despite progress, barriers to lung cancer biomarker testing persist

Source: Smeltzer M, et al. Abstract 3000. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego.

Disclosures: Jain reports no relevant financial disclosures. Healio could not confirm relevant financial disclosures for Levy at the time of posting.

View Details

In this episode, host Shikha Jain, MD, speaks with Alice Chen, MD, about the impact of misinformation and disinformation during elections, the health care issues on the 2024 ballot and more. Content warning: This episode discusses sensitive topics surrounding women’s health and reproductive rights. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Chen 0:32 • The interview 1:38 • How did you get into the public health and advocacy spaces? 1:58 • Have you seen an evolution in medical professionals becoming more involved in politics and advocacy? 5:08 • How has misinformation impacted politics, health care, policy and the election? 7:25 • As health care workers, how do we address misinformation to help our communities and patients? 10:51 • Do you feel that health care workers should use social media for this type of advocacy work? 15:26 • Is there more of a need for health care workers to be doing this work now than it was pre-social media? 18:14 • Jain and Chen on how discussions around politics have changed in the last decade. 26:05 • What are the major health care topics being discussed and impacted by this upcoming election? Why is health on the ballot? 28:33 • Jain and Chen on women’s health and why it matters in this election. 30:58 • What are health care workers doing to promote advocacy? 37:05 • If you could summarize this episode in one minute, what would you want listeners to take away? 45:36 • How to contact Chen 46:11 • Thanks for listening 46:53 Alice T. Chen, MD, is a mom, physician and national leader in public health, physician advocacy and community organizing. She serves as the co-chair of the board of directors of Health Care Without Harm.

Disclosures: Jain and Chen report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Amita Patnaik, MD, FRCPC, about providing patient access to breakthrough drug developments, bringing early phase cancer trials to physicians and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Patnaik 0:21 • The interview 1:23 • How did you decide to become an oncologist, and how did you end up co-founding the START Center for Cancer Research? 1:32 • Can you tell me about START’s overarching purpose and where you see its need being most fulfilled? […] What do you hope START will accomplish in the next five to ten years? 11:33 • How successful has START been at including underrepresented patient populations in clinical data? 17:52 • What are some challenges you’ve found as you have navigated through founding a company and executing its mission? 21:48 • What is next for you? 25:21 • If someone else wanted to create a company like START, what are some tips you would give them? 27:23 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 32:03 • How to contact Patnaik 34:44 • Thanks for listening 35:27 Amita Patnaik, MD, FRCPC, is an internationally recognized medical oncologist and the co-founder of the START Center for Cancer Research.

View Details

In this episode, host Shikha Jain, MD, speaks with Annmarie Ison about developing safe and accurate software, how software can improve health care disparities and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Ison 0:25 • The interview 1:10 • Tell me about how you got into this space […] Can you explain what software development is? 1:34 • What is Elekta and what does the company do? 10:24 • How do you feel that this type of innovation is transforming cancer care and treating oncology patients? 13:19 • How is Elekta and its services helping to address health care disparities? 19:32 • Where do you think AI fits into the bigger picture of the cancer care landscape? 24:53 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 28:29 • How to contact Ison 30:25 • Thanks for listening 31:05 Annmarie Ison is head of customer service for the software business line at Elekta. She has over 25 years of experience as a software development professional, specializing in product development and software architecture for information management systems and radiation therapy delivery devices.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Ison can be reached via email annmarie.ison@elekta.com or via LinkedIn. Disclosures: Jain and Ison report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Brian Fiske about bringing biotech business ideas to fruition, antibody drug conjugate developments and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Fiske 0:21 • The interview 1:45 • How did you get to where you are today, and how did you become interested in this specific area of health care? 2:06 • What is a timeline from start to finish to bringing an innovative idea to fruition? 6:01 • How long does it take to form an actual company from an idea? 11:20 • How do you figure out who you need on your team to move an idea forward? 15:11 • Tell us about your previous positions at biotech companies, and how did they help lead you into your current space? 20:22 • What excites you about your job? […] Why do you feel the drive and desire to do this type of work? 24:40 • Where do you see the work at Mythic Therapeutics doing in the next five to ten years for patient care? 26:27 • How can we work towards making sure this type of innovative work is available and accessible to patients? 29:20 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 31:16 • How to contact Fiske 32:12 • Thanks for listening 32:56 Brian Fiske is chief scientific officer and co-founder of Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate therapies for the treatment of a wide range of cancers.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Fiske can be reached via LinkedIn or the Mythic Therapeutics website. Disclosures: Jain and Fiske report no relevant financial disclosures.

View Details

On this special edition episode, Shikha Jain, MD, with Physicianary’s Hansa Bhargava, MD, and Mend the Gap’s Dagny Zhu, MD, discuss the evolution of empowering yourself and others and advocacy with a panel of guests. • Intro 1:01 • What does it mean to empower women in medicine, and what are the ways that we can really empower others to achieve the things that they may not see for themselves? 2:39 • What are some ways in which you have empowered or hope to empower women in medicine? Are there tips or skills that have worked well? 5:43 • How have you been empowered by others, or have helped others find their voices? 8:38 • Do you agree that the conversation is changing toward a cultural shift in empowerment for women in health care? 13:53 • What are some challenges facing advocacy and empowerment? What do you do when your advocacy work is not being received or it is a struggle to speak up for someone? 18:40 • Emphasizing the importance of communication in advocacy work. 24:00 • Intro to Physicianary’s part 3 on physician burnout and work-life balance. 24:16 • Thanks for listening 25:00 Vineet Arora, MD, MAPP (NAM), is a Herbert T. Abelson professor of medicine, vice dean of education in the biological sciences division and dean for medical education at the University of Chicago Pritzker School of Medicine. She is also an elected member of the National Academy of Medicine. She is a founding member of the 501c3 Women of Impact and advisor to the Women in Medicine Summit. Jennifer Bepple, MD, MMCi, is a double board-certified physician in urology and informatics. She is a member of the American Telemedicine Association, American Urologic Association and American Medical Informatics Association and holds a certification from the American Board of Telehealth and the American Board of AI in Medicine. Hansa Bhargava, MD, is Healio's chief clinical strategy and innovation officer. Listen to her Healio podcast, Physicianary. Shikha Jain, MD, FACP, is a board-certified hematology and oncology physician. She is a tenured associate professor of medicine in the division of hematology and oncology, the director of communication strategies in medicine and the associate director of oncology communication & digital innovation at the University of Illinois Cancer Center in Chicago. Mara Schenker, MD, FACS, FAOA, is an orthopedic trauma surgeon at Grady Memorial Hospital. She is double board certified in orthopedic surgery and clinical informatics. She serves as the chief of orthopedics and associate chief medical information officer. She is an associate professor of orthopedics at Emory University School of Medicine. She serves on multiple boards for medical and digital technology advisory and sits on major national committees for the American Academy of Orthopaedic Surgeons, AAMC, American College of Surgeons and the Orthopaedic Trauma Association. Dagny Zhu, MD, is a cornea, cataract and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. She can be reached on X @DZEyeMD. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Disclosures: The hosts and guest report no relevant financial disclosures.

View Details

In this special 100th episode, host Shikha Jain, MD, speaks with her father, Krishna Jain, MD, about work-life balance pertaining to private practice, improving a fragmented health care system and more. • Welcome to another exciting episode of Oncology Overdrive 1:18 • About Krishna Jain 1:27 • The interview 2:27 • How did you end up in the United States? What was your journey to becoming a world-renowned vascular surgeon? 2:44 • What was it like being a resident back then, especially as someone who came from abroad? 7:30 • After training, why didn’t you go back to India? 10:12 • Shikha Jain on how her father inspired her passion for research and mentorship. 13:19 • Why did you choose to go into private practice, and how did you build your practice and become a leader in this space? 15:18 • The Jains on the importance of being present for and supporting family. 19:16 • How did your entrepreneurial life start? 23:55 • What do your limb preservation centers do? 27:33 • What are some things that need to be done to improve our fragmented health care system? 29:45 • What led you found the South Asian American Vascular Society? 34:16 • How did you end up deciding to go to Kalamazoo, MI instead of going back to India? 39:11 • What are most proud of in your career? 41:28 • What do you want to share with the next generation of surgeons and physicians? 44:07 • The Jains on their relationship growing up and now. 45:44 • If someone could only listen to the last minute of this episode, what would you want them to take away? 47:48 • How to contact Jain 48:48 • Thanks for listening 50:43 Krishna Jain, MD, is a vascular surgeon who has been intimately involved in the growth of office based endovascular centers throughout the country since 2007.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Krishna Jain can be reached via email dockrishna1@gmail.com. Disclosures: Jain reports no relevant financial disclosures.

View Details

In this special throwback episode, Shikha Jain, MD, talks with Olympic champion Kikkan “Kikkanimal” Randall, about how her positive attitude and athlete mentality have helped her navigate a breast cancer diagnosis and treatment, valuable advice for both oncologists and patients and more. • Intro 1:44 • About Randall 1:58 • The interview 3:22 • Tell us a bit about you. Who are you? How did you get to where you are and how did you decide you wanted to be a part of the U.S. Olympic cross-country ski team? 3:51 • How were you diagnosed? 6:12 • How old were you when you first realized that you had this pebble in your breast? 7:33 • What type of mentality is it that makes you such a phenomenal Olympic athlete that you were able to translate into this taking charge of your health and taking charge of your cancer as you move forward? 9:20 • What was the best way for you to cope as you felt this loss of control going through your treatment in certain times? 12:09 • What did you do to prepare for your clinic visits when you were trying to advocate for yourself? 16:17 • Can you talk more about the video blog you kept during treatment? 17:55 • How did you navigate the disease with your son? 21:50 • How long do they recommend for you to wait to try again (to conceive)? Did you have those conversations? 26:17 • Do you feel like you are mentally approaching this period of your post-cancer care or your post-treatment time? 29:58 • Randall running a marathon following the completion of her treatment 32:07 • How did you get involved with Healthy Futures and Fast and Female, and what exactly do they do? 38:08 • Did the way that you participate in advocacy change after you were diagnosed with cancer? 42:46 • One thing you wish oncologists knew when they are treating patients with any kind of cancer, and one thing patients should know if they’re newly diagnosed? 48:09 • How to find Randall 50:26 • Thanks for listening 51:58 Kikkan Randall is an Olympic champion, active mom, cancer fighter and “Get-Activist.” We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Randall can be reached at kikkan.com. Disclosures: Jain reports no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Shyam Natarajan, PhD, about machine learning in cancer research and testing, using technological innovation to address disparities in health care trials and more. • Welcome to another exciting episode of Oncology Overdrive 1:17 • About Natarajan 1:22 • The interview 2:10 • How did you get into the medical technology space? 2:29 • Can you explain what machine learning means? 4:37 • How did you end up co-founding Avenda Health? 7:18 • Do you think that this type of technology is replicable in other disease types as well? […] Where else do you see this being a benefit? 9:53 • When you think about AI, what are the other applications for this type of technology outside of oncology? 11:24 • How do you respond to concerns that AI is becoming too sentient or independent? 12:50 • What are the checkpoints we need to put in place to make sure that biases in AI algorithms do not become the norm? 16:21 • Do you have ways to predict who would benefit from these types of technology, and can you categorize patients into who is appropriate for trialing these technologies? 19:44 • Is there a way to utilize this technology to address disparities in health care? 22:04 • Have you found that there are specific things that make it harder to enroll patients in these particular clinical trials? How do you navigate those? 24:47 • If you had a crystal ball that could see fifty years into the future, where do you see all of this technology going? 27:28 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 30:56 • How to contact Natarajan 31:31 • Thanks for listening 32:22 Shyam Natarajan, PhD, is the co-founder and CEO of Avenda Health, a medtech company focused on improving outcomes for the one in seven men at risk for prostate cancer.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Natarajan can be reached at www.avendahealth.com or via LinkedIn. Disclosures: Jain and Natarajan report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Komal Jhaveri, MD, about breakthroughs in breast cancer treatment, where the field is evolving with anti-body drug conjugates and more. • Welcome to another exciting episode of Oncology Overdrive 1:17 • About Jhaveri 1:21 • The interview 1:41 • How did you get into this highly specialized field? […] How did you become a breast oncologist and find yourself at Memorial Sloan Kettering? 2:07 • As a breast oncologist, what has really excited you in the breast cancer space over the last decade? 5:02 • What do you think is going to happen in the next five to twenty years? Where do you think breast cancer treatment is going to evolve? 13:44 • Do you think AI is going to have a big impact on how we treat patients? 17:47 • If someone could only listen to the last minute of this episode, what would you want them to take away? 19:52 • How to contact Jhaveri 20:34 • Thanks for listening 21:32 Komal Jhaveri, MD, is a breast oncologist & early drug development specialist, clinical director of the early drug development service, and section head of the endocrine therapy research program at Memorial Sloan Kettering Cancer Center (MSK).

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Jhaveri can be reached at her office 646-888-5157, or via email jhaverik@mskcc.org. Disclosures: Jain reports no relevant financial disclosures. Jhaveri reports she is the principal investigator for Genentech’s INAVO120 trial at MSK and co-chair globally.

View Details

In this episode, host Shikha Jain, MD, speaks with David Cosgrove, MD, about implementing real-world utilization of clinical trials, the importance of diversity in clinical trials and more. • Welcome to another exciting episode of Oncology Overdrive 1:17 • About Cosgrove 1:26 • The interview 2:54 • How did you make your way from Ireland to Portland, Oregon? 3:18 • As a fellow GI oncologist, what are you excited about in the cancer research space? 6:13 • How can we realistically address disparities in cancer care to deliver the latest breakthroughs to patients? 8:54 • Jain and Cosgrove on the challenges GI cancers experience in terms of delivery of cancer care compared to colleagues in other spaces. 11:22 • What excites you about what’s happening in oncology right now, and where we’re going in this space? 13:30 • How did you end up as medical director at Compass Oncology? 15:15 • What are you specifically working on now, and where do you hope to see it go in the next five years? 17:25 • How do we get more patients from different backgrounds into clinical trials, and why is it important that we do that? 19:05 • Jain and Cosgrove on challenges facing patient guidelines and qualifications for clinical trials. 21:09 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 23:41 • How to contact Cosgrove 24:45 • Thanks for listening 25:49 David Cosgrove, MD, serves as the medical director of Compass Oncology in Portland, Oregon, and specializes in general adult oncology with advanced subspecialty expertise in gastrointestinal cancers.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Cosgrove can be reached via email david.cosgrove@usoncology.com. Disclosures: Jain and Cosgrove report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with MOLLI Surgical co-founder and CEO, Ananth Ravi, about inventing surgical technology to provide better patient care, addressing inequities in surgical tool access and more. • Welcome to another exciting episode of Oncology Overdrive 1:15 • About Ravi 1:27 • The interview 2:10 • Tell me about how entered this field and how you ended up founding a company that invents surgical instruments. 2:42 • How did you end up moving from Zambia to Canada? 5:02 • Tell me more about MOLLI Surgical. How is this precision surgery unique from what is already out there? 6:47 • What is your background to help you go from ideation to implementation, and how did you take the steps to make your ideas a reality? 10:31 • How do you address rural and global disparities when it comes to accessing these technologies? 16:12 • In an ideal world, where would you see this technology being utilized, and are there any other technologies that you think will revolutionize this type of care? 19:32 • What else excites you about this space? […] How did you find going from the academic space into this role in the business/corporate space? 22:19 • Jain and Ravi on work-life balance. 25:51 • What’s next for you in the next three to five years? 29:26 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 30:15 • How to contact Ravi 30:42 • Thanks for listening 31:39 Ananth Ravi is president, CEO and co-founder of MOLLI Surgical.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Ravi can be reached at www.mollisurgical.com or via email aravi@mollisurgical.com. Disclosures: Jain reports no relevant financial disclosures. Ravi reports he is president, CEO and co-founder of MOLLI Surgical.

View Details

In this episode, host Shikha Jain, MD, speaks with Cyclacel CEO, Spiro Rombotis, MPH, about developing techniques and therapies for drug development, how technology has affected these advancements and more. • Welcome to another exciting episode of Oncology Overdrive 1:15 • About Rombotis 1:23 • The interview 2:21 • Can you tell us about how you ended up in the biotech and pharma spaces? 2:41 • How did you transition to the first CEO of Cyclacel, and what has kept you in the same space for over three decades? 4:45 • Is this how you envisioned your career? How did this vision evolve over the course of your career? 8:53 • What does Cyclacel do, and can you describe the types of innovation you are doing there? 10:19 • With all this new and exciting technology in the field, where do you see epigenetics and precision oncology going in the next ten to twenty years? 15:46 • What are your thoughts on AI in the oncology space? 22:21 • Jain and Rombotis on checks and balances when it comes to AI use in cancer care and clinical trials. 27:53 • What’s next for you? 30:53 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 36:18 • How to contact Rombotis 40:25 • Thanks for listening 40:43 Spiro Rombotis, MPH, is the CEO of Cyclacel. He has over 36 years at three public biotechs and two pharmas.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Rombotis can be reached via email srombotis@cyclacel.com. Disclosures: Jain reports no relevant financial disclosures. Rombotis reports Cyclacel Ltd employment and stock ownership.

View Details

In this episode, host Shikha Jain, MD, speaks with Jennifer Michaelson, PhD, about how to seek out opportunities in the health care industry, making space for diversity in biotech innovation and more. • Welcome to another exciting episode of Oncology Overdrive 1:15 • About Michaelson 1:21 • The interview 2:30 • Can you tell us about how you ended up in the biotech executive space? 2:47 • How do people get involved in this type of work? 12:32 • Tell us about sourcing innovation in biotech, along with the challenges that come with it. 16:46 • How do you consider patient access when thinking about innovations in the biotech space? 21:15 • When you think about the challenges facing leadership and diversity in these spaces, how can we create an inclusive culture in the health care space? What have you done to spearhead a culture of DEI? 23:51 • Jain and Michaelson on organizations infusing DEI concepts into standards of practice and care. 30:58 • If someone could only listen to the last minute of this episode, what would you want them to take away? 32:16 • How to contact Michaelson 33:52 • Thanks for listening 34:23 Jennifer Michaelson, PhD, is chief scientific officer at Cullinan Therapeutics. Michaelson is a biotech executive with 20+ years of industry experience in oncology, immunology, and immune-oncology drug development.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Michaelson can be found on LinkedIn or via email jmichaelson@cullinanoncology.com. Disclosures: Jain and Michaelson report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Sean Bohen, MD, about how cancer therapies are changing how oncology can be discussed, shifting from clinical to industry work and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Bohen 1:04 • The interview 1:30 • Tell us about your journey. How did you become an oncologist, and how did you make the transition into working in the pharmaceutical industry? 1:51 • How did you end up at Olema Oncology after working with other pharmaceutical companies? What was your decision-making process to focus on the industry part of your career? 3:44 • Tell us more about what Olema Oncology does and what your role is there. 6:30 • What do you see coming down the pipeline for breast cancer research and innovation? … What do you think Olema will contribute to that space? 8:58 • Bohen and Jain on the ways in which new treatments have resulted in shifting conversations around cancer care and patient quality of life. 12:45 • If someone in fellowship is interested in working in industry, pharmaceuticals or scientific development, what are the most effective ways to get into this space? 18:21 • Jain and Bohen on changing the mindset and misconceptions around moving between clinical, academic and industry work within the field and after fellowship. 20:52 • What do you see happening in the oncology landscape twenty years from now? 25:46 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 29:19 • How to contact Bohen 30:54 • Thanks for listening 31:52 Sean Bohen, MD, is the President and CEO of Olema Oncology.

View Details

In this episode, host Shikha Jain, MD, speaks with Jonathan D. Licht, MD, about becoming and training qualified leaders in the field, challenges facing health care leaders and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Licht 1:16 • The interview 3:17 • Can you tell us about your journey into hematology-oncology and how you ended up where you are today? 3:58 • How have you found the time and ability to balance and succeed in the research, clinical, translational and leadership parts of your work? 9:05 • What do you suggest to people who are currently trying to get into leadership positions in their early-to-mid career? 12:52 • Do you agree with the sentiment that there are some leaders in the field who are put into positions prematurely or are ineffective? As a leader, how do you address the need for further training of future leaders? 18:39 • What are some of the leadership challenges you have seen in the last several years, and how have you managed to navigate them? 23:20 • How did you use your leadership skills to navigate the first few years of the pandemic, and how are you continuing to navigate delivery of care post-pandemic? 29:23 • Tell me about the process of achieving NCI designation and what it means for your institution. 36:25 • How have you had to navigate state health care legislation and policies challenging reproductive health care? 42:16 • If someone could only listen to the last minute of this episode, what would you want them to take away? 46:13 • How to contact Licht 46:56 • Thanks for listening 48:16 Jonathan D. Licht, MD, is the director of the University of Florida Health Cancer Center.

View Details

In this episode, host Shikha Jain, MD, speaks with Aparna Parikh, MD, about cancer and GI malignancies in the global health space, circulating tumor DNA in the field of oncology and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Parikh 1:07 • The interview 2:08 • What was your path into medicine, cancer care and GI oncology? 2:35 • Tell us about what you do in the global health space and what your thoughts are on colon cancer and GI malignancies in the global health space. 8:07 • Why are we seeing so many more young people being diagnosed with colon cancer in the US and internationally? 12:24 • Do you think US lifestyle and Western diets compared to the rest of the world have contributed to the rise of early colon cancer diagnoses? 15:04 • How can physicians talk about lifestyle, diet and environmental/social determinants of health that impact a cancer diagnosis? 17:52 • Can you provide a brief overview of what is circulating tumor DNA (ctDNA) and liquid biopsy, and how are we using it in this space? 19:44 • Jain and Parikh on ctDNA as an innovation can be transformative in the field of GI oncology. 24:06 • What are your predictions for GI oncology in the next ten to twenty years? 26:06 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 28:44 • How to contact Parikh 30:57 • Thanks for listening 31:57 Aparna Parikh, MD, is a GI oncologist at the MGH Cancer Center where she directs the colorectal research program and young adults CRC program. She is an associate professor at Harvard Medical School and an international expert in CRC and liquid biopsies.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Parikh can be reached via email aparna.parikh@mgh.harvard.edu. Disclosures: Jain reports no relevant financial disclosures. Parikh reports equity in C2i Genomics XGenomes Cadex and Parithera. Advisor/consultant for Abbvie, AZ, Bayer, Biofidelity, Checkmate Pharmaceuticals, CVS, Delcath, Eli Lilly, FMI, Guardant, Hookipa, Illumina, Inivata, Mirati, Pfizer, Saga, Seagen, Taiho, Scare Inc, Science For America, and Value Analytics Lab. She receives fees from Up to Date. She has received travel fees from Karkinos Healthcare. She has been on the DSMC for a Roche study and on Steering Committee for Exilixis. She has received research funding to the Institution from BMS, Daiichi Sankyo, Erasca, Genentech, Mirati, Novartis, PMV Pharmaceuticals, Plexxicon, PureTech, Takeda and Syndax.

View Details

In this episode, host Shikha Jain, MD, speaks with Barnaby Balmforth, PhD, about the evolution of genomics in cancer care, the impact of personalized care tools and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Balmforth 1:12 • The interview 3:01 • How did you get to where you are today? What drove you to become a leader in this space? 3:45 • What is genomics, and why is genomic analysis important in cancer care? 7:18 • Jain and Balmforth on the evolution of technology and challenges facing genomics and diagnostic testing to achieve personalized care for individual patients. 11:59 • In addition to time, can you speak on the challenge of access for this type of technology? 13:20 • How have you been able to implement “next day” test results and reports of your technology? 17:50 • Jain and Balmforth on how Biofidelity’s technology can transform the delivery of care, as well as its psychological and mental impact. 19:06 • What’s coming down the line for you and Biofidelity? 20:56 • What are your thoughts for when you expand beyond thoracic oncology? What are your long-term visions for other disease sites? 24:19 • Do you have any thoughts on AI and how it may influence genomics in cancer care? 25:51 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 28:37 • How to contact Balmforth 30:37 • Thanks for listening 31:10 Barnaby Balmforth, PhD, is co-founder and CEO of Biofidelity. Barnaby has more than 15 years’ experience in the leadership of multidisciplinary technology development.

View Details

In this episode, host Shikha Jain, MD, speaks with Christina Gomez, MD, about the power of patients’ voices, finding joy in physicians work-life balance and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Gomez 1:09 • The interview 1:45 • How did you get to where you are today as a GI oncologist? 2:02 • Have you seen an increase in young people with GI malignancies, and do you have any thoughts as to why we are seeing this change? 5:23 • Where did the inspiration for your book, Stopped in My Tracks: A Physician's Collection of Cancer Patients' Quotes, come from? 9:08 • Jain and Gomez on the power of patient voices. 12:41 • Thoughts on creating another book? 15:30 • Where do you see the landscape of oncology going in the age of machine-learning and new technologies? 17:05 • Jain and Gomez on the different ways physicians can demonstrate personalized care for patients. 21:00 • What should we do as oncologists and as a society to prevent burnout in health care professionals? 24:00 • Jain and Gomez on the mindset shift on work-life-balance for physicians. 27:33 • Jain and Gomez on motherhood and how it can define patient interactions and delivery of care. 29:51 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 34:41 • How to contact Gomez 36:07 • Thanks for listening 37:31 Christina Gomez, MD, is a gastrointestinal medical oncologist at Banner MD Anderson Cancer Center. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Gomez can be reached at christinagomezmd.com, via Facebook or on Instagram @christygomezmd. Disclosures: Jain and Gomez report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Ashley Sumrall, MD, about advocacy outside of their oncology practices and organizations, what lies ahead for the field of neuro-oncology and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Sumrall 1:16 • The interview 2:54 • How did you end up in the neuro-oncology space? 3:21 • As a neuro-oncologist, how do you stay up-to-date with neurology, oncology and medicine? 7:28 • Is there a difference in the way you interact with a neuro-oncologist versus a medical oncologist? 8:58 • What drove you to get into the advocacy space? 10:09 • Do you predominantly do advocacy work through ASCO, or do you do it through other avenues as well? 12:20 • If someone is interested in getting involved in becoming an advocate with ASCO, on the local level or on the national level, what is the best way for them to start that process? 15:24 • How do you talk to people in and outside of organizations about current situations facing health care? 19:40 • If people are interested in learning more about the AMA or getting involved with an organization like the AMA, how can they do so? 22:31 • What do you see coming down the pipeline that you think is going to transform the neuro-oncology space? 27:16 • If someone could only listen to the last minute of this episode, what would you want them to take away? 30:04 • How to contact Sumrall 32:13 • Thanks for listening 32:56 Ashley L. Sumrall, MD, is a neuro-oncologist practicing at Levine Cancer Institute in Charlotte, NC. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Sumrall can be reached on X, formerly known as Twitter: @AshleySumrallMD. Disclosures: Jain reports no relevant financial disclosures. Sumrall reports receiving funding from Bristol-Myers Squibb, Exelixis, Kura Oncology, Novocure and Oncoceutics, and being a consultant for Abbvie, Athenex, Bayer, Exelixis and Novocure.

View Details

In this episode, host Shikha Jain, MD, speaks with George Sledge, MD, about patient feedback benefiting leadership decision-making, the future of precision medicine in oncology and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Sledge 1:03 • The interview 2:59 • How did you become an oncologist? 3:24 • Tell us about your journey into leadership in oncology. 5:27 • Did you continue to see patients while leading organizations? 7:48 • Jain and Sledge on learning from conversations and experiences with patients. 10:57 • How did you end up in your previous position as ASCO president? 12:29 • Do you feel that ASCO is an organization that is adept at adapting to change? 14:37 • Tell us about Caris Life Sciences and how you pivoted to your role as executive vice president and CMO there. 18:44 • Where do you see the future of oncology going? 23:00 • Jain and Sledge on the concerns surrounding artificial intelligence and technology in cancer care and the doctor patient relationship. 26:31 • What is something aspirational that you think could change the way we deliver cancer care years from now? 31:11 • If someone could only listen to the last minute of this episode, what would you want them to take away? 35:21 • How to contact Sledge 36:37 • Thanks for listening 37:10 George Sledge, MD, serves as executive vice president and chief medical officer at Caris Life Sciences. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Sledge can be reached via email gsledge@carisls.com. Disclosures: Jain reports no relevant financial disclosures. Sledge reports that he has stock options with Syndax.

View Details

In this episode, host Shikha Jain, MD, speaks with Jan Kitajewski, PhD, about blending community need with scientific advancement, his role as the director of a cancer care center and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Kitajewski 1:08 • The interview 2:59 • Tell me about how you started and your pathway to this position. 3:26 • You have a very diverse background in various fields of medicine. Was there something that drew you to lead a cancer center? 6:15 • What are your thoughts on how institutions can shift their mindsets toward setting up research that is more inclusive of patient diversity in clinical trials? 9:44 • Jain and Kitajewski on The Immortal Life of Henrietta Lacks, mistrust in the health care system, and how institutions can empower their communities. 14:00 • What does a cancer center director do, and what are some things that people may be surprised to know about your position? 16:30 • Jain and Kitajewski on the University of Illinois Cancer Center applying for NCI designation, and what the process entails. 22:05 • Jain and Kitajewski on the challenges and successes that come with physician leadership when making changes at an institution. 29:28 • What is your vision for the future of the University of Illinois Cancer Center? 34:16 • If someone could only listen to the last minute of this episode, what would you want them to take away? 40:13 • How to contact Kitajewski 40:55 • Thanks for listening 41:35 Jan Kitajewski, PhD, is director of the University of Illinois Cancer Center and a professor and head of the department of physiology and biophysics. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Kitajewski can be reached via email kitaj@uic.edu. Disclosures: Jain reports no relevant financial disclosures. Healio could not confirm relevant financial disclosures for Kitajewski at the time of posting.

View Details

In this episode, host Shikha Jain, MD, speaks with Avital O’Glasser, MD, about the challenges facing non-traditional scholarship, amplifying diverse voices in medicine and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About O’Glasser 1:15 • The interview 2:36 • Jain and O’Glasser on their friendship and how they met. 2:52 • What is non-traditional scholarship, and why is it so difficult for academics to adopt to these practices? 5:16 • Jain and O’Glasser on the added value of non-traditional scholarship in academia and engagement. 11:25 • How can engaging in non-traditional scholarship be leveraged and disseminated along with more “traditionally” recognized ways of CME? 13:33 • O’Glasser on Daniel Cabrera’s More Than Likes and Tweets: Creating Social Media Portfolios for Academic Promotion and Tenure and Ernest Boyer’s The Scholarship of Engagement. 17:19 • Jain and O’Glasser on utilizing digital abstracts in presenting data and pushing back on non-promotable work. 18:30 • How can physicians make sure that information reaches its desired audience through non-traditional scholarship, or provide more educational opportunities about this work? 22:29 • About An Evolution of Empowerment: Voices of Women in Medicine and Their Allies, co-edited by Jain and O’Glasser, and their process in creating this publication. 24:28 • Do you think we’ll collaborate on another book? 32:22 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 35:47 • How to contact O’Glasser 36:45 • Thanks for listening 38:08 Avital O’Glasser, MD, FACP, FHM, is a hospitalist and associate professor of medicine at Oregon Health & Science University. Her clinical practice focus is perioperative medicine, and she is also the assistant program director for social media and scholarship for OHSU’s Internal Medicine Residency Program. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. O’Glasser can be reached on the Women In Medicine blog. Disclosures: Jain and O’Glasser report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with St. Jude’s Steven Gottschalk, MD, and Paulina Velasquez, MD, about the evolution of bone marrow transplant and cell therapy, increasing accessibility to CAR T-cell therapy and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Gottschalk 1:12 • About Velasquez 1:57 • The interview 2:23 • About Gottschalk’s journey and how he ended up in this space. 2:56 • About Velasquez’s journey and how she ended up in this space. 4:16 • Gottschalk on the history of severe combined immune deficiency (SCID), or “bubble boy disease” and his work on developing the cure. 5:04 • When you think about what we have learned about immunotherapy, immune systems and cancer treatment over the last fifty years, did you think we would be where we are today in cancer care? 7:27 • How have CAR T-cells transformed health care so far, and what will they do for the future? 8:53 • What are you currently working on, and what excites you most about that work? 9:57 • Do you think that we can expect a transformation in CAR T-cells being used in solid tumors in the future? 12:34 • How do we prioritize enhanced CAR T-cells in clinical studies? 13:38 • How can we address the challenges facing the delivery of CAR T-cell therapy and make it more accessible to patients? 17:04 • Where do you see CAR T-cell therapy going in cancer care and in immunodeficiencies? 21:03 • If you were interviewed again in five years, what do you think you will be doing then, and what do you think we will be talking about? 25:42 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 30:31 • How to contact Gottschalk and Velasquez 31:22 • Thanks for listening 31:51

Stephen Gottschalk, MD, St. Jude Department of bone marrow transplantation and cellular therapy chair, focuses his research on cancer immunotherapy, cell therapy and stem cell transplantation. The Gottschalk laboratory focuses on Epstein-Barr virus-specific T cells for treating EBV-associated cancers and using genetically modified T cells for cancer immunotherapy.

Paulina Velasquez, MD, St. Jude Department of bone marrow transplantation and cellular therapy, has made significant contributions to the field of immunotherapy, developing novel T-cell therapy platforms for pediatric hematological malignancies. Her team is pursuing projects that address antigen discovery, tumor immune evasion, persistence and efficacy of CAR T cells and cell-cell interaction within the tumor microenvironment.

Disclosures: Jain reports no relevant financial disclosures. Gottschalk reports he is co-inventor on patents and patent applications in the fields of cell or gene therapy for cancer, a member of the scientific advisory board of Be Biopharma and CARGO, and the data and safety monitoring board (DSMB) of Immatics and has received honoraria from TESSA Therapeutics. Velasquez reports patent applications in the field of T-cell immunotherapy.

View Details

In this episode, host Shikha Jain, MD, speaks with Erica Barnell, MD, PhD, about Geneoscopy’s non-invasive screening and early detection technology, helping improve patient compliance for gastrointestinal health and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Barnell 1:07 • The interview 2:05 • Tell me about how you got into this space and co-founded your unique company. 2:30 • How did you find the time to co-find a company on top of completing your PhD program? 4:24 • Barnell on starting Geneoscopy with her brother and working with family. 5:06 • What were the steps you took to make the idea of Geneoscopy happen? 6:08 • Describe the process and technology Geneoscopy is using for early colorectal cancer screening. 7:33 • What makes your non-invasive screening tests different from others? 9:29 • Do you have any advice on how to execute a timeline for physicians and scientists who may have ideas like yours? 11:08 • Jain and Barnell on the advantages of partnering with your network and connections to navigate the challenges of standing up entrepreneurial ventures. 13:36 • How can physicians find resources outside of their network to help them successfully build a company and execute their ideas? 15:20 • Tell me more about what Geneoscopy is looking at outside of cancer. 17:40 • Is this technology something that patients can order directly, and are you thinking of expanding this globally in the future? 19:25 • What do you envision for Geneoscopy ten years down the line? 20:37 • Have you received feedback from other physicians? 21:39 • Jain and Barnell on the positive results of patient compliance with non-invasive screening tests. 23:09 • What’s next for you? Along with growing Geneoscopy, is there anything else that you are working on and passionate about? 24:54 • Can you talk about how Geneoscopy has focused on equitable access in this space? 27:15 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 29:45 • How to contact Barnell 30:20 • Thanks for listening 31:02

Erica Barnell, MD, PhD, is the chief science officer and co-founder of Geneoscopy, a life sciences company focused on transforming gastrointestinal health by empowering patients and providers with innovative tests that help detect, prevent and monitor disease, including colorectal cancer.

View Details

In this episode, host Shikha Jain, MD, speaks with Laura Petrillo, MD, about navigating patients through changes and goals in palliative care, understanding patients living with and surviving advanced cancer and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Petrillo 1:03 • The interview 1:40 • How did you find yourself in medicine, specifically in palliative care and geriatrics? 2:04 • How has the evolution of cancer care and technology impacted the way you engage and deliver palliative care? 6:46 • Jain and Petrillo on the effect changes in palliative care can have on patients. 12:47 • How do you communicate the distinctions between palliative care and hospice care to patients and physicians? 17:19 • Do you think that there are ways for people outside of palliative care can incorporate intentional communication with patients in their care? … When should you refer someone to palliative care? 23:45 • Petrillo and Jain on advanced cancer survivorship and living with advanced cancer. 30:54 • Jain and Reynolds on the progress made in this space and the road ahead. 29:43 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 36:41 • How to contact Petrillo 38:30 • Thanks for listening 38:58

Laura Petrillo, MD, is a palliative care physician-investigator in the Division of Palliative Care and Geriatrics at MGH and an assistant professor of medicine at Harvard Medical School.

View Details

In this episode, host Shikha Jain, MD, speaks with Kerry Reynolds, MD, about immunotherapy-related adverse events, creating educational resources on immunotherapy management and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Reynolds 1:06 • The interview 2:45 • Tell me about how your journey led you to this field of immunotherapy-related adverse events? 3:12 • Jain and Reynolds on how immunotherapy has changed how we talk about cancer care. 5:41 • How did you start the Severe Immunotherapy Complications Service? 6:16 • When you envision this program, what do you feel are the short-term and long-term goals? 10:47 • Can you tell me more about how you care for and manage in-patients through your program? 14:34 • As we learn more, do you think there will ever be a day where all immunotherapy side effects will be able to be managed in the outpatient setting? 16:34 • How do people get into this clinic, and what types of patients are admitted? 18:35 • Tell me about your book, Facing Immunotherapy: A Guide for Patients and Their Families. Who is the best audience for this book? 21:35 • Along with this book, are there other educational resources or initiatives that raise awareness for management of severe immunotherapy complications? 24:56 • Have you encountered any challenges or obstacles while creating and maintaining educational resources and research initiatives? 27:11 • Jain and Reynolds on the progress made in this space and the road ahead. 29:43 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 31:10 • How to contact Reynolds 32:40 • Thanks for listening 33:27

Kerry Reynolds, MD, is an oncologist at the Massachusetts General Hospital Cancer Center and Assistant Professor of Medicine at Harvard Medical School.

View Details

In this episode, host Shikha Jain, MD, speaks with Amy Comander, MD, about incorporating lifestyle changes for cancer patients, developing lifestyle pathways for survivors and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Comander 1:14 • The interview 3:40 • How do you manage to incorporate running on such a high level into your day-to-day life? 4:04 • Tell us about what lifestyle medicine is and why it is so important to include in patient care? 6:43 • How do you suggest oncologists who are interested in integrating lifestyle medicine into their treatment plans communicate these changes to their patients? 10:06 • Jain and Comander on the importance of physical activity in cancer care. 12:09 • Do you have standard recommendations you give to patients to begin incorporating physical activity and exercise to their treatment plan? 13:34 • About Comander’s patient, and her Walk with Me movement. 16:13 • How do you incorporate lifestyle health into survivorship discussions after treatment? 17:12 • Jain and Comander on the evolution of medicine allowing there to be more metrics for holistic care and empowerment for patients. 19:02 • What types of clinical trials are there for lifestyle medicine? 21:19 • Comander on The Diet, Exercise, Lifestyles, and Cancer Prognosis Study (DELCaP). 21:45 • How do you talk to people who may not understand lifestyle medicine or its impact? 23:33 • Can you talk about the PAVING the Path to Wellness program? 24:54 • What is the training process for physicians looking to become a lifestyle medicine specialist? 28:40 • Is there an optimal way to incorporate these specialists in patients’ day-to-day without it being a burden for them? 31:11 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 33:13 • How to contact Comander 34:26 • Thanks for listening 35:37

Amy Comander, MD, is a breast oncologist at the Massachusetts General Hospital Cancer Center.

Disclosures: Jain and Comander report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Pia Chowdry, MD, about access to care in rural communities, how physicians can present information to patients and their caregivers and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Chowdry 1:04 • The interview 1:54 • What was your journey into oncology and how did you end up practicing in Louisiana? 2:07 • Can you talk about your work in racial and ethnic disparities, variables in cancer care, and prevention? 4:18 • Do you feel like being exposed to rural health care settings and challenges has changed the way you practice and talk about care to people outside the area? 6:19 • How do you navigate enrolling patients in rural areas into clinical trials? 10:35 • Jain and Chowdry on misconceptions surrounding clinical trial enrollment in rural areas. 12:42 • What excites you about your job and motivates you to avoid burnout? 13:48 • Has your experience as a caregiver for patients with cancer affected the ways in which you navigate patients and caregivers through treatment and care? 16:25 • Jain and Chowdry on the importance of how physicians present themselves to patients and caregivers. 19:39 • Chowdry and Jain on obstacles facing cancer care in rural areas, as well as benefits. 24:25 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 30:41 • How to contact Chowdry 31:54 • Thanks for listening 32:28

Pia Chowdry, MD, is a medical oncologist with LSU Health in New Orleans, LA specializing in genitourinary malignancies.

View Details

In this episode, host Shikha Jain, MD, speaks with Douglas Micalizzi, MD, and Lecia Sequist, MD, about adopting novel technologies for early detection, public perception of prevention screening and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Micalizzi 1:12 • About Sequist 2:26 • The interview 4:06 • Sequist’s background and how she got into the screening and prevention area of oncology 4:21 • Micalizzi on his chemistry background and how he got into this space 8:03 • About the evolution of early detection and MGH’s Cancer Early Detection and Diagnostics Clinic 11:47 • Who is involved in this clinic and how do you handle a patient’s panic over seeing cancer specialists? 14:30 • Discussion on the New York Times article Not Everything We Call Cancer Should Be Called Cancer and nomenclatures surrounding the various cancer stages and types 19:29 • Public perception of screening and the “push” from people outside of medicine 28:49 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 36:31 • How to contact Micalizzi and Sequist 37:51 • Thanks for listening 39:14

Douglas Micalizzi, MD, is a medical oncologist at Massachusetts General Hospital specializing in breast cancer, early cancer detection and hereditary cancer risk.

Lecia V. Sequist, MD, MPH, is currently the Landry Family Professor of Medicine at Harvard Medical School, the Program Director for Cancer Early Detection and Diagnostics at MGH and the leader of the Cancer Risk, Prevention and Early Detection Program at the joint Dana-Farber/Harvard Cancer Center.

View Details

In this episode, host Shikha Jain, MD, speaks with Mettle Health’s Claritza Rios, MD, and Bridget Sumser, SW, about misconceptions surrounding palliative care, communication training as self-care for physicians and more. • Welcome to another exciting episode of Oncology Overdrive :50 • About Sumser 1:07 • About Rios 1:52 • The interview 2:18 • About Rios and how she got into palliative care 2:47 • About Sumser’s journey and how she ended up in the palliative care space 4:15 • How do we approach the stigma of palliative care? How do we handle the misconception of palliative care and how can we change the narrative? 6:47 • Palliative care and hospice care 15:26 • Patient hope 24:21 • Communication training as a form of self-care 28:52 • Can you tell us about Mettle Health and how people can find you? 31:28 • Holistic care for patients 33:27 • Authenticity and being present for patients 36:58 • If someone could only listen to the last two minutes of this episode, what would you want them to take away? 43:26 • How to contact Rios and Sumser 45:52 • Thanks for listening 47:05

Claritza Rios, MD, is a dedicated physician educator with extensive experience in emergency and internal medicine. Bridget Sumser, SW, became a social worker to help people living with serious illness. Over the course of the last 10 years, she has worked across settings, providing support and companionship to patients, families, community members, and providers.

View Details

In this episode, host Shikha Jain, MD, speaks with Cardinal Health’s Parisa Asgarisabet, PhD and Scott Swain, PhD, MPH about benefits and uses of real-world evidence, the issue of diversity in clinical trials and more.

• Welcome to another exciting episode of Oncology Overdrive 1:11
• About Swain 1:26
• About Asgarisabet 2:45
• The interview 3:30
• About Swain and how you ended up at Cardinal Health 3:50
• About Asgarisabet’s journey and how she ended up at Cardinal Health 5:09
• What is Cardinal Health and why should people know about the work they are doing? 6:37
• How is the work Cardinal Health is doing directly applicable to practicing oncologists? 7:30
• Jain, Asgarisabet, and Swain on Representation of age, race and ethnicity in real-world evidence (RWE), randomized clinical trial (RCT), and Surveillance, Epidemiology, and End Results (SEER) cancer patient registry data in advanced renal cell carcinoma (aRCC). 10:32
• How can we scale real world data in a bigger way and make this the standard as opposed to the exception? 14:02
• Jain and Swain on diversity, equity, and inclusion in the clinical trials design space 17:57
• Asgarisabet and Swain on the economic implications of a lack of diversity in clinical trials 19:53
• Swain and Jain on the importance of community engagement and outreach in achieving diversity of backgrounds in clinical trials 24:42
• What do you think are the next steps to implement real world data in order to make a larger impact? 27:38
• Should real world data be used in concert with randomized controlled trials or should this data be used independently? 29:02
• When we talk about these types of transformation in how we look at diseases and deciding the best plan of action, do you anticipate there being a challenge with insurance companies approving treatments using real world data? 30:27
• If someone could only listen to the last two minutes of this episode, what would you want them to take away? 35:18
• How to contact Swain and Asgarisabet 37:57
• Thanks for listening 39:13

Scott Swain, PhD, MPH is a Director of Regulatory Science and Real-world Evidence with Cardinal Health.

Parisa Asgarisabet, PhD is a Lead statistician in the Real-World Evidence & Insights team at Cardinal Health.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on Twitter and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on Twitter: @ShikhaJainMD. Asgarisabet can be reached via LinkedIn or via email parisa.asgarisabet@cardinalhealth.com. Swain can be reached via LinkedIn or via email scott.swain@cardinalhealth.com.

Disclosures: Jain reports no relevant financial disclosures. Asgarisabet and Swain are employees and shareholders of Cardinal Health.

View Details

In this episode, hosts Shikha Jain, MD, Douglas H. Jones, MD, Amy Comander, MD, Dagny Zhu, MD, Don Dizon, MD, and Mark A. Lewis, MD, discuss the new social media platform, Threads and how physicians can use it for their practice.

• Welcome to another exciting episode of Oncology Overdrive :57
• The topic 1:10
• How many have created a profile on Threads? Why or why not? 2:59
• Dr. Jain has a Thread profile but is unsure how to get more engagement 3:20
• Dr. Lewis has convinced coworkers to use social media but has not used Threads yet 4:54
• Dr. Dizon has a Thread profile but notes that leaving other platforms is leaving those communities and starting all over on a new platform 6:25
• Giving Threads more time to pick up followers and engagement 11:18
• Dr. Zhu has a Thread profile and found it easy to create but engagement is not the same as other platforms 12:17
• Tips and tricks to sharing content on socials, especially Threads 14:33
• Trouble with other social media platforms 17:55
• Tips and tricks to building a community on a social media 20:20
• The power of social media platforms and engagement in established communities 22:30
• Fighting misinformation 25:13
• Platforms versus audience 27:15
• How would you like to see Threads change as a platform? 31:21
• What is the power of TikTok in terms of getting movement among communities? 33:31
• How do you create a profile on Threads? 40:30
• Level of engagement: Twitter vs. Threads 43:31
• The overwhelming number of platforms 52:29
• What is the best platform for physicians to use? 53:41
• Sharable content to post across other platforms 55:34
• Final thoughts 58:09
• Thanks for listening 1:02:13
Douglas H. Jones, MD, is the cofounder of Global Food Therapy, cofounder and president of Food Allergy Support Team and director of Rocky Mountain Allergy at Tanner Clinic. You can follow him on Threads @drdouglasjones.

Amy Comander, MD, DipABLM, is director of breast oncology and survivorship at the Massachusetts General Hospital Cancer Center in Waltham and at Newton-Wellesley, and medical director of the Massachusetts General Hospital Cancer Center in Waltham. She is director of the Lifestyle Medicine Program at the Massachusetts General Hospital Cancer Center. She is also an instructor in medicine at Harvard Medical School. You can follow her on Threads @dramycomander.

Shika Jain, MD, FACP, is an associate professor of medicine with tenure in the division of hematology, oncology and cell therapy at the University of Illinois Cancer Center in Chicago. She is the director of communication strategies in medicine and associate director of oncology communication and digital innovation. She also is consulting editor for Healio Women in Oncology, as well as host of Healio's Oncology Overdrive podcast. You can follow her on Threads @shikajainmd.

Dagny Zhu, MD, is a cornea, cataract, and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. You can follow her on Threads @dzeyemd.
Don S. Dizon, MD, FACP, FASCO, is head of community outreach and engagement at the Cancer Center at Brown University and head of the breast and pelvic malignancies program at Lifespan Cancer Institute. You can follow him on Twitter (X) and TikTok @drdonsdizon.

Mark A. Lewis, MD, is the director of gastrointestinal oncology at Intermountain Healthcare in Murray, Utah, and a medical oncologist specializing in cancers of the gastrointestinal tract and accessory organs. You can follow him on Twitter (X) @marklewismd.

Disclosures: The moderators and panelists report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with the Patient Empowerment Network’s Tracy Rode about providing patients with tools for advocacy, developing accessible patient resources and more.

• Welcome to another exciting episode of Oncology Overdrive 1:11
• About Rode 1:23
• The interview 2:34
• Can you tell us about your journey and how you ended up in this space as such a strong voice for patient advocates? 2:52
• Tell me more about Patient Empowerment Network (PEN), what it does for patients and what it does for health care workers 9:06
• Jain and Rode on how health care workers can improve ways to communicate information to patients in ways they can absorb 14:03
• How do you suggest patients and physicians use the resources provided by organizations like PEN? What is the best way to incorporate education into a clinical visit? 19:06
• Rode and Jain on examples of how much easier it is today for patients to come across misinformation in media, and how organizations can help patients avoid this misinformation 21:50
• Jain and Rode on patient accessibility and benefits to understanding clinical trials 26:35
• Can you share how your cancer diagnosis impacted the way you transitioned into thinking about patient advocacy issues and your approach to them? 29:13
• If someone could only listen to the last two minutes of this episode, what would you want them to take away? 31:35
• How to contact Rode 34:13
• Thanks for listening 35:20

Tracy Rode is the executive director of the Patient Empowerment Network (PEN). Rode brings over two decades of non-profit leadership experience, including working with diverse patient populations to improve patient outcomes and increase access to care.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on Twitter and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on Twitter: @ShikhaJainMD. Rode and the Patient Empowerment Network can be reached at powerfulpatients.org, or via LinkedIn, Facebook, and Twitter @power4patients.

Disclosures: Jain and Rode report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Medidata’s Alicia Staley about enhancing the patient care experience from a former patient’s perspective, building empathetic technical solutions and more.

• Welcome to another exciting episode of Oncology Overdrive 1:11
• About Staley 1:22
• The interview 2:37
• Tell me about your journey and how you ended up at Medidata with your unique skillset? 2:55
• Jain and Staley on medical advances in cancer care, and how delivery of that care has not changed 10:36
• Jain and Staley on the evolution of healthcare as a business and its affects on the doctor-patient relationship 13:27
• What is Medidata and how you end up doing the work you do as VP there? 15:48
• How do you translate and communicate emotion into the bottom line in the space that you are in, and how these changes will help others reach their goals? 20:05
• As a former patient, what are your thoughts on how we can improve clinical trial design? 26:19
• Staley on the importance of finding examples of organizations that have successfully navigated the important conversations surrounding health care 30:29
• If you could create your utopia of a health care system, what do you envision it would look like? 31:19
• If someone could only listen to the last few minutes of this episode, what would you want them to take away? 34:15
• How to contact Staley 35:28
• Thanks for listening 36:21

Alicia Staley has over 20 years of experience in software design and information systems management and is a three-time cancer survivor. At Medidata, Alicia works to infuse the patient perspective throughout the product development lifecycle and help engage patients in novel ways.

Disclosures: Jain reports no relevant financial disclosures. Staley is a full-time employee at Medidata.

View Details

In this episode, host Shikha Jain, MD, speaks with Stephen Beeson, MD, about the challenges physicians face when prioritizing work life balance, components for building skills to lead in health care and more.

• Welcome to another exciting episode of Oncology Overdrive 1:11
• About Beeson 1:23
• The interview 2:36
• Tell me about how you got into the coaching and mentorship space. What is it that inspired or motivated you? 3:08
• Jain and Beeson on empowering physicians to find the joy in their careers while also balancing a family life 9:45
• What have you found is the biggest challenge that health care workers are facing right now? How do you navigate it? 13:26
• Jain on the power of community and the importance of mentors 20:23
• Systemically, how can we make changes to keep physicians in health care on an individual level and on a bigger picture level? 23:41
• Jain and Beeson on the way we compensate physicians for the invisible workload that helps the health care system 29:20
• If someone could only listen to the minute of this episode, what would you want them to take away? 34:25
• How to contact Beeson 34:59
• Thanks for listening 36:00

Stephen Beeson, MD, is founder and CEO of Practicing Excellence, a nationally recognized speaker, physician and author whose life mission is to coach and develop clinicians to be their best.

Learn more about Healio Disruptive Innovators Awards on June 3, 2023 and how to register.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on Twitter and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on Twitter: @ShikhaJainMD. Beeson can be reached at practicingexcellence.com, or email stephen@praticingexcellence.com.

Disclosures: Jain reports no relevant financial disclosures. Beeson is founder and CEO of Practicing Excellence.

View Details

In this episode, host Shikha Jain, MD, speaks with Ken Bloom, MD, FCAP, about developing technologies to assist cancer analysis and pathology, the spatial component of antibody conjugates and more. • Welcome to another exciting episode of Oncology Overdrive 1:11 • About Bloom 1:16 • The interview 2:10 • How did you come into your clinical roles, deciding to become a pathologist and get involved with immunotherapy, and then make the transition into industry? 2:42 • Bloom on how he got involved with breast cancer pathology and precision medicine 7:29 • Bloom on his work on developing new mechanisms for revolutionizing digital pathology 9:52 • How do reference laboratories bring more value to a patient? 15:17 • Jain and Bloom on the evolution of spatial biology in cancer analysis, sequencing and pathology 18:40 • Jain on the challenges facing how health care advances in can be communicated to more physicians and oncologists 21:40 • What are your thoughts on where we’re going now with rising excitement for advancements such as AI? 23:24 • Bloom on Nucleai and how it uses AI to assist in cancer cell analysis 27:56 • Do you think that over the last three years that technology and our understanding of it has been accelerated because of the ways we have adapted during the pandemic? 30:16 • Jain and Bloom on the evolution of science and medicine, specifically in oncology, and how health care systems can change to reflect this evolution 38:59 • If someone could only listen to the minute of this episode, what would you want them to take away? 41:56 • How to contact Bloom 43:42 • Thanks for listening 44:37 Ken Bloom, MD, FCAP, is the head of pathology at Nucleai. He brings more than 35 years of clinical experience in pathology, oncology, telemedicine and bioinformatics. Learn more about Healio Disruptive Innovators Awards on June 3, 2023 and how to register.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on Twitter and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on Twitter: @ShikhaJainMD. Bloom can be reached via email ken.bloom@nucleai.ai. Disclosures: Jain reports no relevant financial disclosures. Bloom is an employee of Nucleai, a spatial biology company.

View Details

In this episode, host Shikha Jain, MD, speaks with Edward Kim, MD about what it means to be a disruptive innovator, how to lead efforts in health care system changes and more. • Welcome to another exciting episode of Oncology Overdrive 1:11 • About Kim 1:19 • The interview 3:00 • What was your journey into oncology and the leadership roles you hold now? 3:27 • Jain and Kim on changing specialties in medical school and in careers 10:45 • Kim on family, his relationship with his daughter, and their viral Taylor Swift concert video 12:34 • Jain on the upcoming Healio Disruptive Innovators Awards and how to register 17:46 • What do you think disruptive innovation means? … Why did you agree to join this initiative? 18:07 • Jain on framing disruptive innovation as a positive within the struggles of the health care system 23:34 • How can we get our systems and delivery of health care to reflect the innovation that we see in medical technology advances, cancer care advances and other advances now to disrupt things for the future? 25:02 • Jain and Kim on perceptions of certain treatments, and how it can prevent forward-thinking innovation 31:36 • Why do we allow ourselves to fall into that trap in health care? … Why have we taken so many years to start addressing these innovations on a larger scale? 32:54 • Kim and Jain on risk aversion for physicians and how questioning systems has evolved 37:36 • If someone could only listen to the few minutes of this episode, what would you want them to take away? 43:02 • How to contact Kim 44:27 • Thanks for listening 45:10 Edward S. Kim, M.D., M.B.A., FACP, FASCO, is physician-in-chief and senior vice president, City of Hope Orange County, and vice physician-in-chief and professor, City of Hope National Medical Center. Learn more about Healio Disruptive Innovators Awards on June 3, 2023, and how to register.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on Twitter and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on Twitter: @ShikhaJainMD. Kim can be reached via LinkedIn, Facebook, on Twitter @DrEdKim, or via email edwkim@coh.org. Disclosures: Jain reports no relevant financial disclosures. Kim reports affiliation with Boerhinger Ingelheim, Genentech and Mirati.

View Details

In this episode, host Shikha Jain, MD, speaks with CureMatch CEO Navid Alipour about the rise of AI in the health care space, how technology can elevate the ways in which we diagnose and deliver health care and more. • Welcome to another exciting episode of Oncology Overdrive :14 • About Alipour :28 • The interview 1:34 • How did you get into the AI space? 2:06 • Can you talk about the evolution of AI from before to where we are now? 4:37 • What are the ways in which you see technologies like CureMatch and CureMetrix having an impact, and what do they do? 9:51 • Alipour and Jain on utilizing AI in ways that will benefit the patient and help providers deliver better care 17:47 • Do you think that there’s a role for AI and these types of technologies in the space of addressing inequities, providing better care and potentially fixing pervasive issues within the modern-day health care system? 26:52 • Jain and Alipour on how quickly technology has evolved, and how it can be utilized in health care detection 32:55 • If someone could only listen to the few minutes of this episode, what would you want them to take away? 38:23 • Alipour and Jain on the importance of patient advocacy 38:58 • How to contact Alipour 41:16 • Thanks for listening 42:54 Navid Alipour is the co-founder and CEO of CureMatch, a company focused on artificial intelligence (AI) technology. He is also a founder of an AI-focused VC fund, Analytics Ventures. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Alipour can be reached at curematch.com and curemetrix.com, or on Twitter @CureMatch and @CureMetrix. Disclosures: Jain reports no relevant financial disclosures. Alipour reports he is the founder of CureMatch.

View Details

In this episode, host Shikha Jain, MD, speaks with Jorge García, PharmD, about the economic benefits of biosimilars, the unique perspective pharmacists can bring to cancer care costs and more. • Welcome to another exciting episode of Oncology Overdrive :14 • About García :23 • The interview 2:44 • How did you enter the world of pharmacy? What was your journey into this field? 3:11 • Can you tell us about what biosimilars are, and how you found yourself in this space? 5:09 • What do you think is the next step for biosimilars? 6:34 • What types of diseases specifically are biosimilars the most exciting for? … What are diseases that biosimilars have the highest impact in? 8:09 • What is Act4Biosimilars, and what do they do? 12:05 • How did you get involved with Act4Biosimilars? 13:04 • Can you expand on what Act4Biosimilars is doing to address inequities and disparities in health care? Is there a way to get biosimilars into the hands of more people who really need it? 14:55 • How do you see the impact of these initiatives and interventions are going to be over the next few years? 17:14 • How do you suggest people who are interested in getting involved in this type of work find this path? 19:31 • Jain and García on his unique perspective of being a pharmacist and having an MBA and understanding cost of care 24:22 • If you had a crystal ball, and you could see five or ten years from now, what do you hope will have changed in the biosimilar news space? 27:13 • If someone could only listen to the two minutes of this episode, what would you want them to take away? 30:36 • How to contact García 31:27 • Thanks for listening 32:32 Jorge García, PharmD, MS, MHA, MBA, FACHE is the assistant vice president at Baptist Health South Florida, where he is responsible for oncology pharmacy services, non-oncology infusion pharmacy services, and sterile compounding quality. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. García can be reached via LinkedIn. Disclosures: García and Jain report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Isabelle Choi, MD, about the use of proton therapy in radiation oncology, improving accessibility to radiation technology and more. • Welcome to another exciting episode of Oncology Overdrive :14 • About Choi :27 • The interview 2:00 • Can you tell us about your journey to become a radiation oncologist? 2:18 • What is proton therapy, and how does it work? 4:57 • What types of cancer can receive proton therapy? 7:35 • What do you look for to decide if somebody should or should not get proton therapy? 10:41 • What are ways to improve the overall outcomes in toxicity during cancer care that you have found in your research in proton therapy? 13:49 • Do you feel like there is a challenge in the equity space? How do we address that in this field that is needed in many populations, but is often not able to be delivered due to lack of resources? 17:51 • Have you had challenges with patients not understanding what radiation oncology is? … How do you address that concern or mistrust that patients may bring? 23:46 • Jain and Choi on multidisciplinary communication when it comes to supporting patients 27:33 • Jain and Choi on the challenges of making extra time for patient communication in the setup of the current health care system and physician burnout 31:22 • If someone could only listen to the last minute of this episode, what would you want them to take away? 36:15 • How to contact Choi 37:27 • Thanks for listening 38:00 Isabelle Choi, MD, is the director of research and clinical director at the New York Proton Center. She is a radiation oncology attending in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Dr. Choi can be reached at www.nyproton.com or on the Memorial Sloan Kettering website. Disclosures: Choi and Jain report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Lipi Roy, MD, about using her voice and platform to advocate for underserved populations, media’s role in educating and empowering the public and more.

· Welcome to another exciting episode of Oncology Overdrive :14

· About Roy :26

· The interview 2:07

· Tell me about how you got to where you are today. 2:47

· About Roy’s work with underserved populations in public health 10:17

· How did you find yourself at Rikers, and how did you feel it was different from what you were expecting? 11:24

· Jain and Roy on discussions toward improving the prison system in the United States 16:41

· How did you break into the media space? … How did you get your foot in the door, take that first step, and navigate that? 19:21

· Jain and Roy on advice for trainees and physicians who want to enter the area of public health media 29:28

· Roy on the close relationship between media and advocacy, and what physicians can do to advocate for social, criminal and gender justice issues 32:52

· Jain and Roy on restructuring the compensation system for physicians in the health care system and compensating physicians who are media contributors 35:03

· If someone could only listen to the last minute of this episode, what would you want them to take away? 39:20

· How to contact Roy 39:40

· Thanks for listening 41:28

Lipi Roy, MD, is an internal medicine physician board-certified in addiction medicine, a sought-after international speaker, media personality as well as host of the YouTube series, Health, Humor and Harmony.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Dr. Roy can be reached on Twitter @lipiroy, Facebook, Instagram @lipiroymd, TikTok @lipiroymd, her website and YouTube channel (subscribe for free!).

Disclosures: Jain reports no relevant financial disclosures. Roy is a faculty speaker/consultant for the Poynter Institute.

View Details

In this episode, host Shikha Jain, MD, speaks with Raj Sundar, MD, about cultural competency and humility in medicine, building a healing relationship with patients and more.

· Welcome to another exciting episode of Oncology Overdrive :14

· About Sundar :21

· The interview :53

· Tell me about how you got to where you are today. What was your journey to becoming a family physician, health equity leader and a podcast host? 1:16

· About cultural competency training in medicine and education 7:37

· Jain and Sundar on the challenges of discussing cultural competency in medical training 12:25

· About cultural humility and incorporating it into medical education and practice 13:10

· What do we need to do to practice medicine and be good citizens in 2023? 15:31

· Jain and Sundar on ways in which we can connect with somebody without saying something that could be culturally insensitive 20:45

· How do we provide cultural competencies and humilities? How do we work towards helping our learners actually gain the skills they need? 23:00

· As someone in a leadership position, how do you incorporate this into your daily practice? 26:33

· Have you seen a shift or changes in your experience over the last couple of years with the pandemic? 32:17

· Sundar on Marshall Ganz’s community organizing models and how they can be applied in the health care industry 35:11

· If someone could only listen to the end of this episode, what would you want them to take away? 37:49

· How to contact Sundar 38:17

· Thanks for listening 38:56

Raj Sundar, MD, is a family physician and community organizer working as a full-spectrum family medicine physician at Kaiser Permanente Washington. Sundar serves as the associate medical director of the Burien Medical Center, where he is the leader of the Health Equity Action Team (HEAT).

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Dr. Sundar can be contacted at healthcareforhumans.org.

Listen to Dr. Sundar’s Healthcare for Humans wherever you get your podcasts!

Disclosures: Jain and Sundar report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Christopher Heery, MD, of Arcellx, Inc. about making the transition from physician to chief medical officer, providing more access and education for clinical trials and more.

Welcome to another exciting episode of Oncology Overdrive :14
About Heery :25
The interview 3:06
Tell us a little bit about your journey. How did you get to where you are today? 3:21
Do you have any advice for those who are interested in making the transition into roles like CMO? How would you guide somebody who is interested in doing that? 7:29
Jain and Heery on the transition in many physicians from patient care to health care leaders and retaining people in clinical medicine 10:41
Jain and Heery on the disconnect in understanding health care costs 13:42
About Arcellx, Inc. and what is coming down the pipeline 15:34
Jain and Heery on how far cancer care has evolved, and the challenge of making this care more accessible to underserved communities 21:30
Jain and Heery on the challenge misinformation creating fear and educating about treatment, clinical trials and immunotherapy 27:23
Jain and Heery on the growing mistrust in the health care system and its effects on the doctor-patient relationship 34:52
If someone could only listen to the last minute or two of this episode, what would you want them to take away? 42:11
How to contact Heery 43:18
Thanks for listening 43:56

Christopher Heery, MD, has been the chief medical officer of Arcellx, Inc. since April 2021. Prior to that, he served as chief medical officer at Precision BioSciences and Bavarian Nordic. Heery is board-certified in medical oncology and internal medicine.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Heery can be reached on Twitter @ChrisHeery.

View Details

In this episode, host Shikha Jain, MD, speaks with Avital O’Glasser, MD, about how digital education credits maximize your personal and professional toolkit, scholarship of engagement and more.

Welcome to another exciting episode of Oncology Overdrive :14
About O’Glasser :27
The interview 1:34
How did you get interested in working with and educating doctors on staying up to date with and including their accomplishments on their CVs? 2:35
How do you take the old system for promotional packets and CVs and incorporate in the new, and still make it something that is valid? 5:12
Jain and O’Glasser on the challenge of digital education on social media being understood and accepted as academia 9:55
Jain and O’Glasser on the impact and benefits of community engagement through social media and using those credentials to tell your “story” in an application 17:46
O’Glasser on Boyer’s model of scholarship 19:53
How do you capture the non-tangible work, such as community-building and mentorship online, that health care workers do? … How do you create that space in a CV, personal statement, or dialogue? 26:36
Jain and O’Glasser on “framing your narrative” on a CV to explain the impact of work and scholarship 33:16
About Reshma Jagsi’s New England Journal of Medicine article, “Promoting Equity for Women in Medicine — Seizing a Disruptive Opportunity” and traditional vs. digital scholarship 38:41
If someone could only listen to the last minute of this episode, what would you want them to take away? 41:34
How to contact O’Glasser 42:55
Thanks for listening 44:26

Avital O’Glasser, MD, FACP, FHM, is a hospitalist and associate professor of medicine at Oregon Health & Science University. Her clinical practice focus is perioperative medicine, and she is also the assistant program director for social media and scholarship for OHSU’s Internal Medicine Residency Program.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. O’Glasser can be reached @aoglasser on Twitter.

Disclosures: Jain and O’Glasser report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Michael Roizen, MD, author and chief wellness officer at the Cleveland Clinic, about developing tools that can help lead to a longer life, public health messaging in media and more.

Welcome to another exciting episode of Oncology Overdrive :14
About Roizen :20
The interview 1:01
How did you get to where you are today, and what was your journey into medicine, health care and everything you are doing outside of clinical medicine? 1:30
How do we de-age ourselves, and what do we do to reboot ourselves? 4:30
Why have we not had a national movement toward this when this is something that many people care so much about? 9:39
Jain and Roizen on retirement age, life expectancy and medical benefits 11:38
Do you think there are any modifications or anything we should think about differently now that COVID is a part of our everyday life? 17:34
What are you covering in this book [The Great Age Reboot: Cracking the Longevity Code for a Younger Tomorrow]? What is its purpose? 19:43
For those of us who are parents, does it matter if you start programming cells from a young age, or is this more for adults? 22:50
How did you get an Emmy? 27:12
What do you think of how communication to the public has changed? … What do you think about where we are going and how things have evolved over the years? 29:08
What’s next for you? … How do you find the time to do all of this? 32:38
About Jain’s non-profits and Roizen’s involvement in gender equity movements in medicine 38:09
If someone could only listen to the last minute of this episode, what would you want them to take away? 44:14
How to contact Roizen and get his book 45:03
Thanks for listening 46:16

Michael F. Roizen, MD, is the emeritus chief wellness officer at the Cleveland Clinic, a professor at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, and author of four #1 New York Times best-selling books.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Roizen can be reached via email at info@greatagereboot.com, or on the website GreatAgeReboot.com.

Find The Great Age Reboot: Cracking the Longevity Code for a Younger Tomorrow wherever you get your books!

Disclosures: Jain reports no relevant financial disclosures. Healio could not confirm Roizen's financial disclosures at the time of publication.

View Details

In this episode, host Shikha Jain, MD, speaks with Edith Perez, MD, about equity initiatives in health care organizations, the evolution of precision oncology and more.

Welcome to another exciting episode of Oncology Overdrive :14
About Perez :21
The interview 1:03
Tell me about yourself and how you got to where you are today 1:20
About Perez’s involvement in many kinds of work in oncology 4:45
How did you get involved in your equity and philanthropy work, and what do you do? 5:44
Do you feel like your work has been changed or modified over the last couple of years with the pandemic, or did knowledge of the problem already exist? 8:30
What changes do you hope to see in the next 5 to 10 years? Long-term, what are the biggest issues that we need to work on improving? 10:12
What does Bolt Biotherapeutics do, and what are their missions and initiatives? 12:26
What do you see happening with Bolt and this kind of technology and therapy over the next 5 to 10 years? 15:01
Jain and Perez discuss the evolution of precision oncology over the years 16:06
As a woman in this field, how did you navigate your path into these leadership roles? 19:17
If clinicians or trainees were interested in getting into the immuno-oncology industry space, how would you recommend they navigate a path? 22:04
Was the transition from industry to a smaller company scary, or did you know this is what you wanted to do next with your life? 24:06
Have you learned your leadership skills, or were they something you were taught? … Is the training more experience/on-the-job, or is it something you seek out? 26:03
If someone could only listen to the last 2 minutes of this episode, what would you want them to take away? 30:03
How to contact Perez 30:51
Thanks for listening 31:36

Edith A. Perez, M.D., is chief medical officer of Bolt Biotherapeutics and an internationally recognized translational researcher and cancer specialist.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Perez can be reached on LinkedIn or via email eperez@boltbio.com.

Disclosures: Jain reports no relevant financial disclosures. Perez reports employment with Bolt Biotherapeutics and Genentech, leadership at Bolt Biotherapeutics, stock and other ownership interests in Genentech/Roche, and a consulting or advisory role at Daiichi Sankyo, Puma Biotechnology, and Seattle Genetics.

View Details

In this episode, host Shikha Jain, MD, speaks with Daniel Golden, MD, about how he has developed educational tools for patients and students, the importance of embracing your niche in medicine and more.

Welcome to another exciting episode of Oncology Overdrive :14
About Golden :17
The interview 1:50
How did you become a radiation oncologist and find your way into this particular field? 2:22
How did you get involved and engaged in the education space, whether it was with patients or with students? 6:23
Have you found that the way you provide these education materials or the way you educate has evolved over time, or do you use one template to provide education? 10:45
Have you gotten any feedback from patients as to what they think about these guides you created? 17:41
Jain and Golden on providing patients with tangible educational information in the age of data, and how the guides to allow patients to feel control and ownership in the cancer space 21:56
About the guides as a tool for doctor-patient engagement, discussion and communication 27:18
About understanding radiation oncology and Golden’s education for trainees 30:05
If there was one thing that you would want people to remember, what would you want them to take away from this episode? 32:21
How to contact Golden 33:42
Thanks for listening 34:55

Daniel W. Golden, MD, MHPE, is associate professor of radiation and cellular oncology at the University of Chicago.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Golden can be reached via email dgolden@uchicago.edu or on Twitter @d_golden.

Disclosures: Golden reports grant funding from Bucksbaum Institute for Clinical Excellence, National Institutes of Health, Radiation Oncology Institute, is the chair of the Radiation Oncology Education Collaborative Study Group (501c3) and manages RadOncQuestions.com. Jain reports no relevant financial disclosures.

For more information on Radiation Oncology Education Collaborative Study Group: https://roecsg.org/.

ROECSG Downloadable Guides:
CEBRE – ROECSG
CEBRE en Español – ROECSG
CoGBE – ROECSG

For more information on Scholars in Oncology-Associated Research (SOAR) cancer research program: https://voices.uchicago.edu/pritzkersoar/

View Details

In this episode, host Shikha Jain, MD, speaks with retired Commanding General of the US Army, Lieutenant General Mark Hertling, about the similar responsibilities of doctors and soldiers, what makes a strong leader in the health care space and more.

Welcome to another exciting episode of Oncology Overdrive :14
About Hertling :21
The interview 2:51
How did you start in your career, and how did you get to where you are today? 3:11
What types of things do you think translate over, and how do you use the skills that you’ve been cultivating over the years [as a General] to translate into the health care world? 7:40
Do you see a lot of parallels between leading on the battlefield and leading on the “front lines” of health care during the pandemic? … What have you been advising over the last several years on how to be effective leaders during a time like this? 11:17
Do you think that there is utility and benefits in getting more physicians into leadership in concert with the administrations that are already there to help regain some of the autonomy that’s been lost in health care over the last several decades? 17:52
Jain and Hertling on training physicians and nurses in leadership and creating trust between physicians and administrators in health care organizations 22:55
How being a leader as a physician can look like many different skillsets in health care 28:43
Can you talk about the war in Ukraine, and how it’s impacting us here in the US? 31:41
Is there anything to be optimistic about when it comes to climate change, the ongoing pandemic and war? … Do you think that any of these things can be righted? 36:10
If someone could only take one snippet of this entire episode, what would you want them to take away and remember? 41:40
How to contact Hertling 41:58
Thanks for listening 43:32

Lieutenant General Mark Hertling is a retired Commanding General of the US Army, and a military and national security analyst for CNN/CNN International.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Hertling can be reached on Twitter @MarkHertling, or by searching “Mark Hertling” on LinkedIn.

Disclosures: Hertling and Jain report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with hospitalist and host of Explore The Space Podcast, Mark Shapiro, MD, about honing impactful communication skills, how health care workers can get involved in politics and more.

Welcome to another exciting episode of Oncology Overdrive :14
About Shapiro :44
The interview 3:15
Tell us about your journey. How did you get to where you are today? 3:29
Have you noticed that more health care workers seem to be pushing their way into the political arena? Is that something we need more of in health care? 5:56
How did you start that exploration into advocacy work? … How did you find the courage to start that mission-driven work? 8:22
Why should we not frame “gun control” in the way it’s been framed in the past, and what do we need to do to move things forward? 11:44
How did you learn to become such a good communicator when it came to public health messaging? How did you develop that ability to have those conversations? 16:53
Shapiro’s experience with improvisational comedy and its effect on social interactions with physicians 19:46
Why are we talking more about climate change as it relates to healthcare and medicine, and why are we the people who should be talking about it? 22:53
Tell us about your experience of being invited to the White House. How did that happen, and what did you do there? 28:38
How do you realize that amplifying others’ voices is something that you can do? … What was the strategy you enacted to become such a phenomenal amplifier? 32:10
How did you come up with the concept of the Med Lasso podcast? 35:52
If somebody could only listen the last minute or two of this episode, what would you want them to take away? 39:25
How to contact Shapiro 39:56
Thanks for listening 41:38

Mark Shapiro, MD, is a practicing hospitalist & is the creator, producer & host of Explore The Space Podcast.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Shapiro can be reached on Twitter @ETSshow, via email mark@explorethespaceshow.com, on Instagram @explorethespaceshow, or by searching Mark Shapiro, MD on LinkedIn.

Listen to Explore The Space Podcast wherever you listen to podcasts, and visit www.explorethespaceshow.com for more information.

Disclosures: Jain and Shapiro report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Roberta Gebhard, DO, and Pringl Miller, MD, about empowering physicians through education and advocacy, getting the right help to overcome and protect against workplace inequities and more.

- Welcome to another exciting episode of Oncology Overdrive :14
- About Gebhard :24
- About Miller 1:12
- The interview: 2:01
- Dr. Miller, you went from surgeon to expert in palliative care in hospice, to advocate … What has been your path to where you are today? 2:12
- Dr. Gebhard, tell us more about your journey to ascend into leadership positions and how you ended up where you are today 3:57
- About Physician Just Equity (PJE) 5:42
Why do you think this is so important right now? … Why do you think now is the time to form an organization like this [PJE], and what are you hoping to accomplish? 9:22
Can you talk about some of the people you’ve helped? Are there any stories of individuals that you feel are especially important or that are ongoing that we should know about? 13:06
About the case of Dr. Vilasini (AKA Vilasni) Ganesh 16:55
How does something like this happen? 20:37
Is there any benefit to partnering with groups like The Innocence Project or organizations that have worked in this space before? 23:04
What can people do to help with Dr. Ganesh’s case? 25:53
Who do you recommend come to PJE? … When should someone reach out to PJE? 27:06
If somebody could only listen to the last minute of today’s episode, what would you want them to take away? 33:03
How to contact Miller 33:57
How to contact Gebhard 34:16
Thanks for listening 34:58

Roberta Gebhard, DO, is a family practice physician in Western New York, currently on the Board of Directors of Physician Just Equity. She was the 2019-2020 president of the American Medical Women’s Association, is currently the AMWA representative to the American Medical Association Women Physician Section Governing Council and was the founder of the AMWA Gender Equity Task Force.

Pringl Miller, MD, is a board-certified general surgeon and hospice and palliative medicine specialist. She is the founder and ED of Physician Just Equity (PJE) and a co-founder of the Surgical Palliative Care Society.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Dr. Gebhard can be reached via email at docgebhard@gmail.com or on Twitter @drrgebhard. Dr. Miller can be reached via email at founder.physicianjustequity@gmail.com or on Twitter @pringlmillermd. Visit the Physician Just Equity website by searching physicianjustequity.org or on Twitter @equitydocs.

Disclosures: Gebhard, Jain, and Miller report no relevant financial disclosures.

To make a donation to the Dr. Vilasini Ganesh legal fund: bit.ly/vganesh

References:

https://www.beckershospitalreview.com/legal-regulatory-issues/california-physician-sentenced-to-5-years-in-prison-for-billing-fraud.html

https://cdn.ca9.uscourts.gov/datastore/memoranda/2021/05/24/18-10133.pdf

https://greenandassociates.blogspot.com/2018/09/sentencing-update-california-doctor.html

https://indicanews.com/2021/11/09/doctor-vilasini-ganesh-claims-courts-railroaded-her-in-fraud-case/

https://www.ndtv.com/indians-abroad/indian-origin-doctor-vilasini-ganesh-her-husband-conspires-to-commit-health-care-fraud-in-california-1909639

https://www.nripulse.com/indian-american-doctor-sentenced-to-63-months-in-prison-says-the-criminal-justice-system-failed-her/

https://www2.mbc.ca.gov/BreezePDL/document.aspx?path=%5CDIDOCS%5C20190124%5CDMRAAAGL1%5C&did=AAAGL190124172444350.DID

https://youarewithinthenorms.com/2021/09/11/alpha-phi-alpha-fraternity-speaks-out-against-injustice-done-to-gregory-belcher-md-orthopedic-surgeon-by-federal-government-for-wrong-date-on-a-217-00-invoice-now-faces-prison-time-a-naval-office/

View Details

In this episode, host Shikha Jain, MD, speaks with hematologist, medical educator and University of Pennsylvania director of the women’s thrombosis and hemostasis program, Ariela Marshall, MD, about fertility advocacy for patients and physicians, navigating the medical system as physician parents and more.

Welcome to another exciting episode of Oncology Overdrive :14
About Marshall :18
The interview: 1:44
How did you get involved and interested in doing the work in the fertility space, and what led you to that world? 3:02
Do you think that some of this is due to the fact the way our healthcare system is set up in a way where women’s symptoms are often disregarded, or the way we look at our patients is riddled with implicit bias? Why do you think that this is such a huge problem? 7:30
What has been your experience with physicians and physician infertility? … Is it something that we have ideas of how we can really move the needle and change this? 11:26
Have you noticed any sort of culture shift, or do you think we still have a really long way to go in that space? 17:38
Creating and normalizing an office environment where family is a priority 22:48
Cultures and responses to reproductive health in the physician workforce 29:03
How the overturning of Roe v. Wade is going to impact infertility and fertility treatment 32:06
Is there hope for the future when we talk about these things? … Looking at the data, is this something that we can strive for or may change? 21:03
What are your future plans for this type of work and your research? What are you thinking the next steps are going to be? 26:48
If somebody could only listen to 2 minutes of today’s episode, what would you want them to take away? 39:56
How to contact Marshall 41:16
Thanks for listening 43:00

Ariela Marshall, MD, is a hematologist, medical educator and the director of the Women’s Thrombosis and Hemostasis program at University of Pennsylvania in Philadelphia, Pennsylvania.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Marshall can be reached on Twitter @AMarshallMD.

Disclosures: Jain and Marshall report no relevant financial disclosures.

View Details

In this episode, host Shikha Jain, MD, speaks with Ragy Girgis, MD, MS, about findings from the Columbia Mass Murder Database he co-developed, the associations between mental illness and mass shootings and more.

Content Warning: This episode contains discussions of gun violence and suicide. Listener discretion is advised.

Welcome to another exciting episode of Oncology Overdrive :14
About Girgis :24
The interview: 1:51
How did you find yourself working in psychiatry, and specifically, in the field of looking at mass murders and gun violence? 2:04
Do you have any thoughts on mental health in the US vs. other countries? How do you address people who give that rhetoric when they talk about these scenarios? 4:27
Why create this database? ... What do we learn from this type of work? 5:26
Why do you think people commit mass murder with guns? 8:17
Do you have any thoughts as to why we’re seeing more of these happening now than we did in the past? 11:05
Is there any data or difference in violence committed by women vs. men, and whether they are more likely to be prone to violence or more likely to execute a mass shooting event? 13:11
What do we need to do make these changes and advocate for this? … How do we take this data, this information, and then move on it? 17:29
Is there hope for the future when we talk about these things? … Looking at the data, is this something that we can strive for or may change? 21:03
What are your future plans for this type of work and your research? What are you thinking the next steps are going to be? 26:48
If someone could only listen to 2 minutes of this episode, what would you want them to take away? 29:14
How to contact Girgis 30:10
Thanks for listening 31:14

References:

Brucato G, et al. Psychol Med. 2021;doi:10.1017/S0033291721000076.

Ragi Girgis, MD, MS, is associate professor of clinical psychiatry at the Columbia University Department of Psychiatry and New York State Psychiatric Institute.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Girgis can be reached by searching Ragy Girgis on Columbia University’s website.

Disclosures: Jain reports no relevant financial disclosures. Girgis reports he is a paid consultant for IMS Expert Services, a paid consultant for Noble Insights research firm, and receives royalties from Wipf and Stock Book.

View Details

In this episode, host Shikha Jain, MD, speaks with Helio Genomics’ Justin Chen Li about the ways in which AI has been incorporated into oncologic care, how this technology can improve care disparities, and more.

Welcome to another exciting episode of Oncology Overdrive :13
About Li :18
The interview: 1:10
How did you end up in this field? 1:25
What is AI-based cancer detection? What does Helio Genomics do? ... Is it really science-fiction, or is it actually happening in today’s day and age that we can actually use in our clinical practice? 4:07
There’s different ways AI has been incorporated into oncologic care. What’s different about what you do? 6:25
What is it that you’re doing in the HCC (hepatocellular carcinoma) space right now? 7:47
Is this something that can help in that space? Is that why this is so innovative? 9:43
If you could wave a magic wand and say, “We want Helio Genomics to be able to accomplish this,” what would you want to make happen for cancer patients from using your technology? 10:45
Do you think there’s a way that this could potentially address health care disparities that exist in cancer care and potentially improve the gaps in care that we often see? 12:40
How has COVID and the pandemic impacted your team — your technology, your delivery of care and your planning? … Have there been things that have forced you all to change the way you think about or improve things based on the last couple of years? 15:02
What’s next for you? Where do you see yourself growing and going next from here? 18:26
Is this something you envision expanding into other aspects of health care? Is there a way to expand what you’re doing outside of cancer care? 19:42
If someone could only listen to 2 to 3 minutes, or the last couple of soundbites of this episode, what would you want them to remember and take away? 21:26
How to contact Li 22:20
Thanks for listening 22:50

Justin Chen Li, is CEO of Helio Genomics, an AI-based cancer detection company focusing on next generation sequencing tests.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Li can be reached on LinkedIn by searching Justin Chen Li, or email justin@heliogenomics.com.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Li is CEO of Helio Genomics.

View Details

In this episode, Eleonora Teplinsky, MD, discusses the evolution of advocacy in the health care space, the challenges cancer patients face after the overturning of Roe v. Wade, and more.

Disclaimer: The views and opinions expressed in this episode are those of the speakers and do not necessarily reflect the views or positions of Healio.

Welcome to another exciting episode of Oncology Overdrive :13
About Teplinsky :17
The interview: 1:07
How did you decide to do breast oncology, and how did you decide to incorporate advocacy into that space? 1:38
Have you seen an evolution in health care “advocacy”… and has it evolved over the years in how we engage in it? 4:47
Can you talk a little bit about these types of policy changes, how they’re going to impact our patients? 8:59
How on earth could we say, “This is a medical emergency” and not be prosecuted for terminating the pregnancy in some of these states? 14:41
How can we call ourselves innovative, and forward-thinking, and breaking edge technology in health care and then make decisions that put us back hundreds of years? 16:32
What do we suggest to our colleagues, and patients, in these states if they find themselves in this situation? 20:37
When there is such massive disapproval for the reversal of Roe v. Wade, how do we move forward, and how do we make this change? 27:02
What do you do to keep pushing forward? How do you keep yourself engaged and motivated to try and make changes when it feels like nothing you’re doing is actually making a difference? 27:59
Have you ever had a situation where somebody has come up to you in real life and said, “I didn’t like what you put on social media”? Has a patient recognized you in a positive or negative way from something that you put out into the ethos of social media or beyond? 29:48
Let’s say you had a magic wand, and you could wave it and make things exactly the way you want. What do you think needs to be done, specifically for the Roe v. Wade situation? … What would you think would be the best way to move forward? 32:43
If someone could only listen to the last 30 seconds of this podcast, what would you want them to take away? 34:37
How to contact Teplinsky 35:15
Thanks for listening 36:02

Eleonora Teplinsky, MD, is head of breast medical oncology at Valley-Mount Sinai Comprehensive Cancer Care; clinical assistant professor of medicine at The Icahn School of Medicine at Mount Sinai.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Teplinsky can be reached @drteplinsky on Twitter and Instagram, or at drteplinksy.com.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Teplinsky reports no relevant financial disclosures.

View Details

In this episode, Guido Baechler discusses the pandemic’s impact on healthcare and preventative health, personalizing cancer care after diagnosis and more.

Welcome to another exciting episode of Oncology Overdrive :13
About Baechler :18
The interview: 1:00
Tell me how you got into this space and into this role. 1:24
Do you feel like the COVID pandemic has changed the way many people are thinking about healthcare and preventative health? ... What do you think the impacts of the pandemic have been on all of what you do? 4:09
Do you feel like it’s impacted the way that patients are deciding what care to receive? … Do you feel that this is one way to get around that challenge? 5:15
Explain to me what this company does…what all do you offer, and what’s different about your company than other companies that do similar work? 6:34
With the way we’re able to personalize cancer care after diagnosis, it sounds like you think we might even be able to personalize the screening of cancer care, from everything from pancreatic cancer to colon cancer and other malignancies? 9:55
How do you explain all of this to patients? … How does this type of information […] translate [that] to patients and help them understand why this is such an innovative thing for them? 10:56
Do you think that there’s going to be even more beyond this where it can become even more simple to do this type of screening? … Do you think we’re heading in a direction where it might be even simpler to do screening in the future? 14:02
If you had a magic wand, and you could do whatever you wanted or say whatever you wanted and it would happen, what would be your ideal situation to see for screening in five, 10, 15 years? 15:43
When you thought about your career, is this something that you thought you’d be doing? Is this something, twenty years ago, you thought you’d be talking about – colon cancer screening and innovative ways to prevent cancer with new technologies? 17:20
Do you feel that there’s any utility for this type of screening to be applied, or to be implemented in a younger population … with the increase in number of young people we’re finding with new colon cancers now? 18:21
Is there anything you wanted to cover that we didn’t get a chance to talk about yet? 19:53
How to contact Baechler 20:50
Thanks for listening 21:23

Guido Baechler is CEO and director at Mainz Biomed.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Baechler can be reached at mainzbiomed.com or by email at guido.baechler@mainzbiomed.com.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Baechler reports he is CEO and director at Mainz Biomed.

View Details

In this episode, Andrea Conners discusses her career in pharmaceuticals, her journey to becoming an advocate for patients with cancer and the Patient Empowerment Network.

Welcome to another exciting episode of Oncology Overdrive :13
About Andrea Conners :20
The interview 1:37
Conners' journey to the role of executive director for PEN 2:04
The golden age of cancer care: targeted therapy 8:25
How does PEN's role grow, develop and change as cancer care evolves? 10:37
PEN, digital platforms and barriers 17:24
The Digital Sherpa Program and addressing disparities among the patient population 21:12
Getting the most out of the resources available 26:47
The future of cancer care 28:19
Conners’ one pearl? 31:00
How to contact Conners? 32:21
Thanks for listening 33:07

Andrea Conners is the Executive Director of the Patient Empowerment Network.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Conners can be reached by email at andrea@powerfulpatients.org.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Conners reports no relevant financial disclosures.

View Details

In this episode, George P. “Jeep” Naum III, MD, and Vanessa Naum, MBA discuss their journey to becoming relationship coaches, the often seen themes in relationships of physician couples and more.

Welcome to another exciting episode of Oncology Overdrive :13
About Jeep Naum :23
About Vanessa Naum 1:16
The interview 2:28
How did you end up where you are today? How did you end up in this space? 3:07
So, do you do the majority of your sessions over Zoom? Is it in person? Or have you modified with the pandemic? 10:05
Are there any themes that you see especially in physician couples? Do you think that there’s certain things you see more often in physician couples whether it’s a dual physician family or whether it’s one physician in the family? 11:10
How do you advise people to work through things like a lack of introspection from one partner to the other? 19:41
What do you do in those situations where there’s a difficulty in changing? 22:09
Discussion on the constant attack on marriage and causes for divorce 30:49
Jeep Naum’s one pearl 33:06
Vanessa Naum’s one pearl 33:57
How to reach the Naums 36:26

George P. “Jeep” Naum III, MD, is a physician, coach and author. Dr. Naum has been a physician for 31 years and a couples coach for 27. Since 2019, he and his wife Vanessa have been specializing in physician marriage coaching. As a married physician and coach, he has mixed his passion for coaching doctors and helping them find love and a deeper connection in their marriage and career life.

Vanessa Naum, MBA, is sex and relationship coach trained in a philosophy that is a holistic and loving approach to sex and relationship coaching that invites people to move beyond shame, clarifies their needs and boundaries, live emotionally connected and erotically embodied lives an experience the joy and satisfaction of great sex and authentic relationships.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. The Naums can be reached on Twitter @drjeepvanessa or at their website, bestfriendsagain.com.

Disclosures:

Jeep Naum reports no relevant financial disclosures. Vanessa Naum reports no relevant financial disclosures. Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, Amy Comander, MD, DipABLM, Beth Frates, MD, FACLM, and Michelle Tollefson, MD, FACOG, DipABLM, discuss their journeys in the breast cancer treatment and awareness space, the importance of wellness and lifestyle support in both patients and specialists and their new personal well-being resource PAVING the Path to Wellness Workbook.

Welcome to another exciting episode of Oncology Overdrive :13
About Dr. Amy Comander, Dr. Beth Frates and Dr. Michelle Tollefson :24
The interview 3:06
What was Dr. Comander’s path to the wellness and lifestyle space of medical care? 3:36
How did Dr. Frates enter the wellness and lifestyle space of health care? 5:40
Tollefson’s path into the wellness and lifestyle space 8:10
The challenges faced in the wellness community and “wellness” as a buzzword 12:10
The importance of evidence-based lifestyle medicine in caring for mind and body 15:02
The origins of PAVING the Path to Wellness Workbook 19:21
Approaching wellness in patients compared with specialists 25:55
What are the most important “bite-sized” takeaways from this episode? 33:40
Thanks for listening 42:13

Amy Comander, MD, DipABLM, is the Medical Director and Director of Breast Oncology and Cancer Survivorship at the Mass General Cancer Center in Waltham, as well as at Newton Wellesley Hospital and is an Instructor in Medicine at Harvard Medical School.

Beth Frates, MD, FACLM, is a Clinical Assistant Professor at Harvard Medical School’s Department of Physical Medicine and Rehabilitation.

Michelle Tollefson, MD, FACOG, DipABLM, is an Associate Professor at Metropolitan State University of Denver and a Physician at St. Luke's Medical Clinic.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Commander can be reached on Twitter @DrAmyComander. Frates can be reached at www.bethfratesmd.com and on Twitter @BethFratesMD. Tollefson can be reached on Twitter @DrMTollefson.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Comander, Frates and Tollefson report no relevant financial disclosures.

View Details

In this episode, Richard L. Schilsky, FSCT, FASCO, FACP, MD, discusses his involvement with ASCO, ideas for making a more equitable health care system and thoughts on the current state of oncology.

Welcome to another exciting episode of Oncology Overdrive :13
About Schilsky :24
The interview 2:50
How did you end up in medicine, in oncology and then in GI oncology? What was your path into this space? 3:01
What was it that drew you to becoming involved in ASCO and seeing where your journey would lie in that space? 9:15
What is something that surprised you in oncology in your career? Is there anything you can look back and think that was really shocking, or that was a major development that you never could have imagined happening in the cancer space? 14:14
How has COVID impacted what you've seen for your patients and your colleagues? 23:04
What do we need to do to work towards a more equitable health care system and more equitable cancer care for our patients? 28:07
Looking back at your career, do you think where we are now is where you expected? 33:24
If somebody could only listen to the last 2 minutes of this episode, what would you want them to take away? 40:11
How to contact Dr. Schilsky 41:26
Thanks for listening 42:13

Richard L. Schilsky, FSCT, FASCO, FACP, MD, is the former chief medical officer and executive vice president of ASCO. He is also the former chief of hematology/oncology in the Department of Medicine and deputy director of the University of Chicago Comprehensive Cancer Center.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Schilsky reports no relevant financial disclosures.

View Details

In this episode, Aaron Gerds, MD, discusses his work on clinical trials and suggestions to improve the process, the impact of COVID on these trials and his involvement in ASH Clinical News.

Welcome to another exciting episode of Oncology Overdrive :13
About Gerds :17
The interview 1:50
I'd love to hear kind of your journey to becoming a physician and then really becoming this sub specialized hematologist. 3:25
You work in clinical trials, and really in the infrastructure of how to implement and make clinical trials most effective for patients. So how did you get into that? And why do you feel like that's important? What do you do in that space that you feel is going to make a difference? 5:22
Is there a way for us to fix the process of getting a clinical trial open and completed? 7:01
Let's say you were king for a day, and you were able to disrupt the entire system and fix it. What would you do? 12:47
How has COVID impacted what you've been doing in clinical trials and infrastructure? What are the things that have really been challenges? 16:08
So how did you get involved in ASH Clinical News? What exactly is your role? And why do you think something like ASH clinical news is important? 25:58
If somebody is interested in becoming that voice of getting accurate information out there, whether it's through ASH or through another forum, what do you suggest for them? What's the best way to get engaged and involved in that space? 29:56
If somebody could only listen to the last minute of this conversation, what would you want them to take away? What are the key takeaways from today's conversation that you would want someone to remember? 34:33
How to contact Dr. Gerds 36:05
Thanks for listening 37:08

Aaron Gerds, MD, is assistant professor in medicine, specializing in hematology and medical oncology, at the Cleveland Clinic Taussig Cancer Institute and editor-in-chief of American Society of Hematology Clinical News.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Gerds can be reached on Twitter @AaronGerds.

Disclosures: Gerds reports no relevant financial disclosures. Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, Christine Hodgdon and Julia Maués, co-founders of Guiding Researchers and Advocates to Scientific Partnerships, and Stephanie L. Graff, MD, FACP, discuss the organization’s mission and the importance of patient advocacy.

Intro :01
Welcome to another exciting episode of Oncology Overdrive :13
Guest introduction :23
About GRASP :28
About Maués :36
About Hodgdon 1:07
About Graff 1:40
Can you tell us a little bit about GRASP? 2:21
Julia, what was your journey to get into this process? 5:47
Graff how are you involved with GRASP? 9:26
How was something like GRASP not already implemented? 13:30
Julia and Christine, did you have any scientific background before you started doing this? 16:48
Why is advocacy so important? 19:12
Have you guys had any negative responses with this whole patient advocate title? 24:58
Sometimes women’s symptoms and concerns are written off or ignored … Julia is that something you’ve personally experienced or seen? 29:59
Hodgdon’s one pearl 39:08
Maués’ one pearl 39:56
Graff’s one pearl 40:59
How to contact Graff 42:23
How to contact Maués 42:38
How to contact Hodgdon 42:57
Thank you so much for your time 43:27

We’d love to hear from you! Send your comments/questions to oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday, @ShikhaJainMD, @christeeny513, @itsnot_pink, @DrSGraff and @GRASPtweets.

Stephanie L. Graff, MD, FACP, joined Lifespan Cancer Institute at Brown University in Providence, Rhode Island as the director of breast oncology in the summer of 2021. Prior to joining the team at Lifespan/Brown, she was director of both the breast program and clinical research at the Sarah Cannon Cancer Institute at HCA Midwest and associate director of the Breast Cancer Research Program at Sarah Cannon Research Institute and national breast lead for the Sarah Cannon Cancer Network’s clinical programs. In addition, Graff serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research.

Christine Hodgdon, is a co-founder of GRASP.

Julia Maués is a co-founder of GRASP.

Disclosures: Graff, Hodgdon and Maués report no relevant financial disclosures. Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, Benjamin Derman, MD, discusses his work on addressing disparities in hematology and oncology, the impact the pandemic has had on these issues and much more.

Welcome to another exciting episode of Oncology Overdrive :13
About Derman :17
The interview 1:33
The field you’re in is super, super specialized … can you tell me a little bit about your journey into how you went into medicine, how you went into this field and then how you started working on some disparities work as well? 1:46
Do you feel like you’re now in a place where you have to explain things to people where it sounds like science fiction, but it actually is really a powerful way to treat a lot of cancers? 8:36
How did you start working in the disparities space and why do you think it’s so important that we really focus on this as a topic that we address within oncology and hematology? 12:53
How do we change how we are treating patients from a system level? A national level? An institutional level? 18:52
Do you think, in the last year and a half, COVID has helped or hurt this mission? 21:21
We talk about informed decision making and patients think they are making an informed decision, although the information they have is from a bunk source. 27:04
A discussion on how to guide patients, risk levels/factors and navigating life 27:53
What are your thoughts on testing for spike antibodies? 33:12
The impact of telehealth and telemedicine on patients during the pandemic 39:36
Derman’s one pearl 40:59
How to contact Derman 41:58

Benjamin Derman, MD, is an assistant professor of medicine in the University of Chicago Department of Medicine’s section of Hematology/Oncology.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Derman can be reached on Twitter @BDermanMD.

Disclosures: Derman reports no relevant financial disclosures. Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, Larissa Nekhlyudov, MD, MPH, and Andrea Anampa-Guzman, discuss their journeys into oncology and survivorship, how internists and primary care physicians fit into this space, and more.

Welcome to today’s episode of Oncology Overdrive :13
About Nekhlyudov :32
About Anampa-Guzman :57
The interview 1:40
Larissa … could you share a little bit about your journey into this particular path and realm of medicine? 1:43
So then how did you find yourself in the survivorship space? 4:14
Andrea, tell me a little bit about you … I’d love to hear about your journey into medicine and how you fell into this type of research and this type of interest so early in your career? 9:43
Larissa … what exactly is a general internist’s role when it comes to talking about cancer care? 15:29
How do you feel your role has evolved over the years? 19:40
Do you feel like as you learned more, the type of care you provide has changed? 21:12
Do you feel like people understand you a bit more? 21:50
Andrea, what do you see are the biggest differences about how we approach survivorship in America compared with Peru? 23:20
When it comes to doing this type of work, do you specialize in one specific type of malignancy? 27:40
Anampa-Guzman’s one pearl 36:35
Nekhlyudov’s one pearl 37:03
How to reach Anampa-Guzman 38:30
How to reach Nekhyludov 38:42

Larissa Nekhlyudov, MD, MPH, is a professor of medicine at Harvard Medical School and is a practicing internist at the Brigham and Women’s Hospital in Boston, Massachusetts. She is also clinical director of internal medicine for cancer survivors at the Dana Farber Cancer Institute where she offers clinical care for long-term survivors of childhood and adult cancers.

Andrea Anampa-Guzman, is a medical student at the National University of San Marcos in Lima, Peru. She is a team member of the clinical problem solvers and a member of the social media committee for the American Society of Clinical Oncology and the American Medical Women’s Association.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Dr. Nekhlyudov can be reached on Twitter at @DRN_CancerPCP. Anampa-Guzman can be reached on Twitter and Instagram @AndreaAnampaG.

Disclosures: Anampa-Guzman and Nekhlyudov report no relevant financial disclosures. Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, Ankit Kansagra, MD, discusses his path into medicine, how medical institutions can address systemic diversity issues and his personal experience as a physician during the pandemic.

Welcome to another exciting episode of Oncology Overdrive :13
About Kansagra :20
The interview 2:10
Tell me about how you chose to go into this field 2:28
What brought you into that space of trying to figure out how to increase this more diverse population of patients? 5:30
What are some ways that institutions can look internally at their infrastructure? What are some systemic issues that you think could be fixed in other institutions? 11:28
Have you seen a shift in the way people are discussing these types of things, whether it comes to cancer or COVID? 14:51
How have you been navigating this last year and a half treating your patients? 17:09
What are you advising your patients right now when they are asking you about this third dose of the vaccine? 20:24
Kansagra’s one pearl 24:29
How to reach Kansagra 26:12

Ankit Kansagra, MD, is an assistant professor in the department of internal medicine at UT Southwestern Medical Center. He specializes in stem cell transplants and CAR-T therapy and has particular expertise in caring for patients with plasma cell disorders, including multiple myeloma, amyloidosis, and Waldenström macroglobulinemia. He is the assistant director of UTSW’s Outpatient Stem Cell Transplant Program.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Kansagra can be reached on Twitter @KansagraMD.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Kansagra reports no relevant financial disclosures.

View Details

In this episode, Lance Baldo, MD, discusses the use of MRD testing, T-cell receptor profiling, and how lessons from the COVID-19 pandemic will help shape the future of cancer vaccines.

Welcome to another exciting episode of Oncology Overdrive :13
About Baldo :17
The interview 1:20
Tell me about your journey 1:38
Did you question your decision to leave clinical practice for an entrepreneurial venture? 2:36
What does Adaptive Biotechnologies do? 3:43
What is Minimal Residual Disease (MRD) testing and how is it used? 4:27
Are you looking only at hematologic malignancies? 5:35
How are experts using MRD testing in clinical practice? 6:31
Why do you think MRD testing is important in treating cancers? 7:24
Is Adaptive working on drug discovery and development related to MRD testing? 9:20
Personalized care and how real life feels like science fiction 12:02
Doing what’s best for the patient 15:33
Tell me about T-cell receptor profiling 18:02
Tell me about neo-antigen-based therapy 21:10
Are these types of technologies available outside of large, academic institutions? 22:49
Has COVID impacted the way you and your team think about implementing therapies and innovation? 25:03
Do you think what we’ve learned over the last year will help with the creation of future cancer vaccines? 29:59
If we spoke again in 10 years, what would you hope to have done? 31:25
Baldo’s take-home message 37:42
Where to find Baldo 38:57

Lance Baldo, MD, is chief medical officer of Adaptive Biotechnologies.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Baldo can be reached on LinkedIn, via email at lbaldo@adaptivebiotech.com and at www.adaptivebiotech.com.

Disclosures: Baldo is chief medical officer of Adaptive Biotechnologies. Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, Kevin C. Soares, MD, discusses his path to GI oncology, how immune therapy complements surgical interventions, and shares his thoughts on how the pandemic will impact medical practices.

Welcome to another exciting episode of Oncology Overdrive :14
About Soares :20
The interview 1:58
Can you tell us a little bit about how you chose your specialty and how you got where you are today? 2:39
How did you decide that you wanted to incorporate researching immunotherapy in these particular diseases? 5:53
What are you looking at when it comes to immune therapy complementing surgical interventions? 8:48
How do patients typically respond when you talk about new trials and studies? 12:56
How did the pandemic impact you and your patients and your practice? What was the last year and a half like? 16:07
Do you think COVID is going to change the way we practice medicine as a whole? 19:42
You’re seeing these patients with these cysts … what is your role in those patients’ cases? 24:45
Could you talk a little bit about what image-guided ablation is and how it works? 29:00
When you retire what would you like to have seen happen in this particular space? 33:24
Soares’s one pearl 36:35
Where to find Soares 37:24

Kevin C. Soares, MD, is a surgical oncologist at Memorial Sloan Kettering Cancer Center, with specialty training in hepatopancreatobiliary surgery.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Soares can be reached by calling 212-639-3195 or by going to www.mskcc.org.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Soares reports no relevant financial disclosures.

View Details

In this episode, Priya U. Kumthekar, MD, discusses her entry into the field of neuro-oncology, her insight into translational medicine and its applications outside of medicine, and more.

Welcome to another exciting episode of Oncology Overdrive :14
About Kumthekar :28
The interview 1:51
How did you become a neuro-oncologist? 1:57
What do you think is so great about being able to translate what we’re able do at work to how we live at home? 5:29
The importance of transparency at home 9:20
What do you do for your own mental health? 13:13
Do you think that after this last year and a half are there going to be things that stick with you after this pandemic that have permanently changed you? 16:46
How did you manage virtual learning with your kids and everything else that you were doing? 20:16
Do you foresee changes in the health care system in the practice of oncology? 23:53
Is there anything that you say to yourself or do for yourself when you’re at your breaking point? 28:30
Kumthekar’s one pearl 33:26
How to contact Kumthekar 34:18

Priya U. Kumthekar, MD, is an associate professor of neurology (neuro-oncology) and medicine (hematology and oncology) at Northwestern Medicine. Kumthekar is a UCNS-certified neuro-oncologist dedicated to patient care, moving the field of oncology forward primarily through her leadership on brain metastases and primary brain tumor clinical trials.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Kumthekar can be reached by email at priya.kumthekar@nm.org.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Kumthekar reports no relevant financial disclosures.

View Details

In this episode, Carol L. Brown, MD, discusses her role as chief health equity officer at MSKCC, her thoughts on the future of structural inequities, strategies to diversify clinical trials, and more.

Welcome to another exciting episode of Oncology Overdrive :13
About Brown :19
The interview 3:00
Can you tell us a little bit about your path? 3:10
Are equity officer positions helping institutions, or are they there as window dressing? 6:46
Are you optimistic with where we’re going? Do you think we’ll come out of the pandemic with new solutions to break down these structural inequities? 11:35
We must keep focusing on these issues 18:04
How does fear play a role in how we speak with and care for our patients? 21:22
Do you have ideas on how we can get more heterogenous populations in clinical trials? 33:00
Brown’s take-home message 40:09
How to reach Dr. Brown 41:11

Carol Brown, MD, is a board-certified gynecologic oncologist; senior vice president and chief health equity officer at Memorial Sloan Kettering Cancer Center and the incumbent of the Nicholls-Biondi Chair for Health Equity. She also serves as vice chair of Health Equity in the department of surgery. She holds academic appointments as attending surgeon and member at MSK, and professor, obstetrics and gynecology at Weill Cornell Medical College.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Brown can be reached by email at healthequity@mskcc.org.

Disclosures: Brown reports no relevant financial disclosures. Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, Julie Rubinstein, MBA, discusses her journey into the cancer space, the importance of personalized medicine and how her father’s cancer diagnosis played a role in her career.

Welcome to another exciting episode of Oncology Overdrive :13
About Rubinstein :19
The interview 1:53
Can you tell us a little bit about your journey into this space? 2:04
So, they were in Seattle, and you were in New York … way before this pandemic happened were you working virtually that many years ago? 11:54
When you were first in the immunotherapy space at the beginning of your career, did you guess that it would have such a huge impact in the cancer space? 14:46
How did your father’s cancer diagnosis influence the way you navigated your career in the oncology space? 24:26
Discussion on the importance of personalized medicine 35:12
Rubinstein’s one pearl 42:20
How to reach Rubinstein 43:35

Julie Rubinstein, MBA, is the president of Adaptive Biotechnologies. She currently oversees Life Sciences Research, Clinical Diagnostics, Drug Discovery, Corporate Marketing and Business Development functions.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Rubinstein can be reached via email at jrubinstein@adaptivebiotech.com.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Rubinstein is the president of Adaptive Biotechnologies and has stock and other ownership interests in the company.

View Details

In this episode, Stephanie Graff, MD, FACP, shares the details of her new role at Lifespan Cancer Institute at Brown University, how social media has impacted her career and the importance of fostering relationships with patients.

Intro :13
About Graff :18
The interview 2:09
How did you end up in medicine and oncology? 2:32
How did this opportunity come about, and how did you make the decision? 6:47
How do you advise folks regarding career transitions or first jobs out of training? 16:45
How do you think social media has impacted your career? What do you say to the naysayers? 22:14
How have you utilized ASCO throughout your career? 32:24
What do you hope to accomplish at Brown? 37:14
Graff’s take-home message 41:13
How to find Graff 42:18

Stephanie Graff, MD, FACP, joined Lifespan Cancer Institute at Brown University in Providence, Rhode Island as the director of breast oncology in the summer of 2021. Prior to joining the team at Lifespan/Brown, she was director of both the breast program and clinical research at the Sarah Cannon Cancer Institute at HCA Midwest and associate director of the Breast Cancer Research Program at Sarah Cannon Research Institute and national breast lead for the Sarah Cannon Cancer Network’s clinical programs. In addition, Graff serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD. Dr. Graff can be found on Twitter @DrSGraff.

Disclosures: Graff reports no relevant financial disclosures. Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, Edward S. Kim, MD, MBA, discusses his path to oncology, how he views disruption in health care, and the ways he’s innovating to help both patients and providers.

Intro :13
About Kim :22
The interview 2:03
How did you end up in medicine and oncology? 2:20
What do you think it means to have disruptive or innovative health care strategies? 15:24
Oncology care provides the opportunity for disruptive innovation 21:10
How do you decide which risks to take? 25:59
Taking risks can help move the needle forward 37:52
Kim’s take-away from this episode 38:58
How to reach Kim 39:58

Edward S. Kim, MD, MBA, FACP, FASCO, is physician-in-chief at City of Hope Orange County and vice physician-in-chief of City of Hope National Medical Center.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD. Dr. Kim can be reached by email at edwkim@coh.org and on Twitter @DrEdKim.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Kim reports no relevant financial disclosures.

View Details

In this episode, VK Gadi, MD, PhD, discusses his path to oncology, the importance of positively disrupting the health care system and how innovation can change the traditional model of health care.

Intro :13
About Gadi :29
The interview 2:00
What was your journey to where you are now? How did you get here? 2:31
What led to the transition from the Fred Hutch Cancer Center to the University of Illinois? 3:53
How was it moving across the country in the middle of a global pandemic? 5:31
Do you have thoughts on what we need to do in health care to disrupt the system and rebuild or recreate a better, more equitable system in general and, specifically, in cancer care? 7:05
Do you think that this pandemic is going to lead us in a path where people will be more open to a new way of thinking? 9:17
Do you think that coming out of this pandemic are there going to be any tangible or major changes that you’ve seen in your own practice or seen across the board that may continue to make access or delivery of care better? 11:53
How do you go about that process of figuring out how to continue to lead equitably but also making sure you’re leading equally? 19:54
How do you guide women to keep their eyes open and continue to evolve and grow while finding the right people to help them grow and create those steeping stones to success? 24:42
Cancel culture in medicine 28:36
Dealing with institutions with a negative organizational culture 33:16
Gadi’s one pearl of wisdom 36:39
How to reach Gadi 37:37

VK Gadi, MD, PhD, is professor and director of medical oncology in the department of medicine, and associate director of translational oncology at UIC Cancer Center.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD. Dr. Gadi can be reached by email at vkgadi@uic.edu and on Twitter @DrVKGadi.

Disclosures: Gadi reports research funding from Agendia; intellectual property of Chimerocyte; consultant/speaker for Hologix and he is founder of SEngine Precision Medicine. Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, psychiatrist Michael F. Myers, MD, discusses the use of couples therapy in households comprised of single- and dual-physician families, the rate of depression among members of the medical field, and more.

Intro :13
About Myers :18
The interview 1:27
How did you get into the field of psychiatry? How did you end up in a space with such a specialized area of expertise? 1:44
Have you noticed there’s a big difference in those different family dynamics between families with single-physician households and dual-physician households in those types of patients that you treat? 5:21
You actually decided in your career to also include couples therapy … how did you decide to incorporate it into your practice? 10:03
Have you found that the rate of depression among medical students, doctors is higher than the general population? Why are we seeing these high rates of depression? 14:20
How do we continue to move the needle against these stigmas of mental illness among medical health professionals? 18:16
Have you noticed more suicides among students and residents? Have you been asked to talk to people in that space? Is there something we can do to help support students and residents? 25:58
What has it been like in this last year in taking care of doctors? Has your practice changed at all and have you noticed things are different this year? 33:29
If someone could only listen to the last two minutes of this episode what would you want them to take away? 39:21
Where can people purchase your book, “Becoming a Doctor’s Doctor,” and how can people find you if they want to connect with you? 40:11

Michael F. Myers, MD, is professor of clinical psychiatry and recent past vice-chair of education and director of training in the Department of Psychiatry & Behavioral Sciences at SUNY-Downstate Health Sciences University in Brooklyn, NY. He is also the author of “Becoming a Doctor’s Doctor.”

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD. Dr. Myers can be reached at his website, www.michaelfmyers.com, on Twitter @downstatedoctor and on Linkedin.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Healio was unable to confirm relevant financial disclosures for Myers at the time of publication.

View Details

In this episode, Shikha Jain, MD, goes from being the interviewer to interviewee as she discusses her path to medicine, the importance of good mentorship, and how social media could shape the future of medicine.

Intro :13
About Jain :33
The interview 2:16
How did you get to where you are today? Did you always know you wanted to be a physician? 2:23
You work tirelessly to promote the advancement in women in medicine … can you tell us a bit about why this cause is so important to you? 7:42
Who were your mentors and were there female leaders who inspired you during your residency or fellowship? 17:33
Do you have any advice for early career female physicians? Or is there anything you wish you could tell yourself if you could go back in time? 23:51
How did you get started using social media professionally, and how do you hope platforms like Twitter and TikTok will shape the future of medicine? 29:55
What has the past year been like for you in terms of navigating the pandemic? Are there any self-care strategies you rely on? 38:00
If someone could only listen to the last two minutes of this episode, what would you want them to take away? 43:01

Shikha Jain, MD, is a board-certified hematology and oncology physician. She is an assistant professor of medicine in the Division of Hematology and Oncology, the Director of Communications Strategies in Medicine and the Associate Director of Oncology Communication and Digital Innovation for the University of Illinois Cancer Center.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD.

Disclosures: Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, Angela Rasmussen, PhD, discusses her path to becoming a virologist, her insights on risk mitigation strategies, and what’s next in her career.

Intro :13
About Rasmussen :16
The interview 1:06
Can you tell us a little bit about how you became a virologist? 1:18
Did you ever imagine that you would be in the eye of the storm, so to speak, in a public health crisis like the one we’re facing now? 2:53
Can you kind of walk us through, from when this whole pandemic started, to now, how has your role evolved? 4:43
So, were you surprised, as all of this was happening, when this pandemic became such a polarizing subject? 9:23
What do you think is needed today in order for us to actually fix our response? 14:36
What is it going to take to get that faith in the medical and scientific communities and public health messaging when there was already so much hesitancy to begin with? 18:24
When do you think we’re going to stop wearing masks, realistically, in this country? 24:45
The importance of funding for preventive health infrastructures 31:26
Were you, by any chance, on Jeopardy!? What was that experience like? 35:49
You mentioned you’re making a big move, an international move … where are you going and what are you going be doing in the next part of your career? 39:57
Rasmussen’s one pearl of wisdom 43:33
Where to find Rasmussen 44:09

Angela Rasmussen, PhD, is a virologist currently affiliated with the Georgetown Center for Global Health Science and Security. In spring 2021, Rasmussen will be starting a lab at the Vaccine and Infectious Disease Organization-International Vaccine Centre, a vaccine research institute at the University of Saskatchewan. She is a member of the Verena Consortium, a multi-disciplinary, international effort to predict and study emerging viral pathogens.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Rasmussen can be reached on Twitter @angie_rasmussen and via her website, angelarasmussen.org. Follow us on Twitter @HemOncToday @ShikhaJainMD.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Rasmussen reports no relevant financial disclosures.

View Details

In this episode, infectious disease expert Jasmine Marcelin, MD, FACP, shares her journey into the field, and we discuss the need to address racial disparities in health care and how to approach vaccine hesitancy in minority communities.

Intro :15
About Marcelin :35
The interview 2:44
How did you end up in Nebraska doing infectious disease? 3:37
Did you ever imagine you would be navigating through a pandemic? 9:19
What has the pandemic really been like? 11:50
Do you think more people are becoming aware of the longstanding racial disparities in health care? 19:50
Have you seen, over the last year, any organizations, institutions, societies or people who have implemented effective solutions? 23:33
Is vaccine hesitancy something you foresee being a problem in minority communities? 29:40
Seeing what you’ve seen over the last year, are you optimistic that we’re going to come out of this with a more equitable system? 44:03
Marcelin’s one pearl of wisdom 51:41
Where to find Marcelin 52:19

Jasmine Marcelin, MD, FACP, is a Caribbean native born on the island of Dominica. She is an assistant professor of infectious diseases at the University of Nebraska Medical Center, who helps run the center’s internal medicine residency and antimicrobial stewardship programs.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Jasmine Marcelin can be reached on Twitter @drjrmarcelin. Follow us on Twitter @HemOncToday @ShikhaJainMD.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Marcelin reports no relevant financial disclosures.

View Details

Rachel Solnick, MD, MSc, is an emergency medicine physician and health services researcher. In this episode, we discuss her journey into public policy, how to navigate through medical misinformation on social media and why doctors should be policy advocates.

Intro :14
About Solnick :16
The interview 1:10
How did you become an ER physician focusing on policy and research? What was your journey to get to this point in your career? 1:13
Did you start this research policy fellowship before the pandemic? 3:37
How did this whole process start on writing your study and what were the results? 4:48
How did you set up the study? 9:50
What did you find? 13:30
Do you think that the messenger is just as important? 14:37
What’s your opinion on people who put information out there that’s factually inaccurate? How can people get through the noise? 18:09
Have you found that the way you’ve interacted on social media has changed over the last year throughout the pandemic? 19:37
Why should we as doctors be advocates and why should we be working on policy? 23:20
How has it been like being a physician clinically during this time? 31:53
Solnick’s one pearl of wisdom 35:10
Where to find Solnick? 36:05

Rachel Solnick, MD, MSc, is an emergency medicine physician and health services researcher. She is currently a second year National Clinical Scholars Program research fellow and practicing physician at the University of Michigan Emergency Department and the Institute for Healthcare Policy and Innovation.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Rachel Solnick can be reached on Twitter @RachelSolnickMD. Follow us on Twitter @HemOncToday @ShikhaJainMD.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Solnick reports no relevant financial disclosures.

View Details

Anne Peled, MD, is a practicing breast and plastic surgeon. In this episode, we discuss the importance of representation in the medical system and how being a breast cancer survivor has changed the way she practices medicine.

Intro :04
About Peled :15
The interview 1:07
Peled’s journey to becoming a practicing breast cancer and plastic surgeon 1:51
Does your family practice near you? 3:59
Has becoming a breast cancer survivor changed how you practice medicine? 5:15
Addressing the disruption in care involved with cancer treatments 9:11
Were you able to continue working throughout your cancer treatment? 11:26
How did you manage work-life balance while going through cancer treatment? 12:44
As both a breast surgeon and a patient, have you come across perspectives where some breast cancer initiatives can do the opposite of what they were intended to do? 17:14
Have you found effective ways to address disparities in breast cancer care? 19:15
The importance of representation in the medical system 20:43
How effective has the use of social media for information been for you, and how did you get involved doing it through Instagram? 24:18
The impact of social media and expanding communities 26:44
Peled’s take-home message 29:18
How to reach Dr. Peled 30:31

Anne Peled, MD, is a practicing breast cancer and plastic surgeon based in San Francisco. She is the co-director of the Breast Care Center of Excellence at Sutter Health California Pacific Medical Center.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Peled can be reached on Instagram @drannepeled. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Peled reports no relevant financial disclosures.

View Details

In this episode, former journalist Chrissy Farr joins me to discuss 2020, including reporting on a pandemic, attacks on the media, the most unbelievable stories of the year and her new role at OMERS Ventures.

Intro :13
About Farr :17
The interview 1:01
How did you end up in journalism? 1:08
What was it like being a journalist in 2020? 2:47
How did you figure out what to focus on when covering the pandemic? 7:09
Were you concerned you might publish a story that would need a retraction? 9:22
Is this the first time you’ve dealt with targeted attempts to discredit the media? 19:00
Comments from readers, patients 24:02
Journalists are in the category of “hero” 25:45
Looking back at 2020, are there any stories that seemed unbelievable? 27:41
Did you notice that politics and other topics became more intertwined with your health reporting? 32:21
It’s interesting how people change the narrative based on their agenda 35:49
Tell us about your new role with OMERS Ventures 39:44
What made you leave journalism? 42:08
Farr’s take-home message 45:15
Thank you, Chrissy 47:09

Christina (Chrissy) Farr is principal investor, Health-Tech Lead at OMERS Ventures and a former journalist.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Farr can be reached @chrissyfarr. Follow us on Twitter @HemOncToday @ShikhaJainMD.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Farr is principal investor at OMERS Ventures.

View Details

Patricia W. Finn, MD, is a physician scientist focusing on the microbiome and immune-mediated pulmonary diseases. In this episode, she shares her experiences in health care, effects of the pandemic and the importance of personal care.

Intro :14
About Finn :30
The interview 2:17
Can you tell us a little bit about your journey? 2:37
Were there things in your career path that led you to feeling like you needed to do more for those who might be marginalized or might face challenges similar to what you faced? 8:40
How have you seen the emotional impact of the pandemic manifest in the health care systems and how have you helped people manage or deal with that? 21:39
Has the way this pandemic has ebbed and flowed changed the way you’ve approached things? 28:26
When all is said and done, do you think we’ll leave this pandemic with some positive changes to the health care system as a whole? 33:40
Some of the positive innovations that have come from the pandemic 37:40
Finn’s one pearl 44:35
How to contact Finn 45:24

Patricia W. Finn, MD, is the Earl M. Bane professor chair and head of the department of medicine and the associate dean for strategic initiatives and an associate program director for the medical scientist training program at the University of Illinois at Chicago. She is a physician scientist focusing on the microbiome and immune-mediated pulmonary diseases including sarcoidosis, transplantation, lung injury and asthma.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Finn can be reached by email at pwfinn@uic.edu. Follow us on Twitter @HemOncToday @ShikhaJainMD.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Healio was unable to determine relevant financial disclosures for Finn at the time of publication.

View Details

Mark A. Lewis, MD, is a medical oncologist specializing in cancers of the gastrointestinal tract and accessory organs. In this episode, he talks about his path to becoming a GI oncologist and living with multiple endocrine neoplasia type 1.

Intro :14
About Lewis :27
The interview 1:14
How did you become a GI oncologist? What was your journey to get to where you are now? 1:57
Did you make a conscious decision that you were going to start sharing what was going on with you? 8:15
How Lewis’s social media engagement made an impact on Jain and the humanization of oncologists 20:52
The risk benefits of masks and vaccines in the age of COVID-19 27:27
The benefits and drawbacks of telehealth in the age of COVID-19 33:29
How have Lewis and his wife navigated Lewis’s diagnosis and the pandemic? 40:01
Lewis’s one pearl of wisdom 44:29
Where to find Lewis 46:51

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Lewis can be reached on Twitter @marklewismd. Follow us on Twitter @HemOncToday @ShikhaJainMD.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Lewis reports no relevant financial disclosures.

View Details

Megan L. Ranney, MD, MPH, FACEP, is an emergency physician, researcher, public health advocate and media commentator. In this episode, she discusses the Lifespan Center for Digital Health and what “new power” means for bringing change in the health care field.

Intro :14
About Ranney :27
The interview 2:28
How did you get to where you are? 3:09
You recently launched this Lifespan Center for Digital Health which you are the director of, can you tell us about that and how it came about and what it does? 4:55
What has this pandemic been like for you as a practitioner? How have you either changed the way you’ve practiced medicine or how has it impacted you as an ER physician? 11:46
How do you keep yourself motivated to keep doing the work? How do you not let it beat you down? 17:00
The need for doctors to practice self-care during the pandemic to avoid burnout 20:09
What “new power” means and how Ranney’s organizations practice it and exemplify it on a daily basis 22:15
For physicians who are practicing medicine whether in academia or a more traditional setting, how do you suggest they infuse “new power” into their jobs, careers and their health care systems? 26:19
Do you think or have you found that this pandemic has changed the way people think about some of the hierarchical structures? 32:47
Getting funding for the firearm injury research project 35:30
Ranney’s one pearl of wisdom 44:40
Where to find Ranney 45:37

Megan L. Ranney, MD, MPH, FACEP is an emergency physician, researcher, and national advocate for innovative approaches to public health. She holds the Warren Alpert Endowed Associate Professor of Emergency Medicine at Alpert Medical School of Brown University and is founding director of the Brown-Lifespan Center for Digital Health. She is an editor for Annals of Emergency Medicine, a Fellow of the fifth class of the Aspen Institute’s Health Innovators Fellowship Program, and a member of the Aspen Global Leadership Network. She has received numerous awards for technology innovation, public health, and research, including Rhode Island Woman Physician of the Year and the American College of Emergency Physicians’ Policy Pioneer Award. She is also a frequent media commentator on outlets ranging from CNN to the Atlantic to the New York Times regarding the value of a national public health strategy.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Ranney reports receiving NIH and CDC funding, as well as funding from Medscape to provide education on COVID-19 testing, and volunteer positions on board of directors of AFFIRM Research and GetUsPPE.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Megan Ranney can be reached on Twitter @meganranney. Follow us on Twitter @HemOncToday @ShikhaJainMD.

View Details

Julie Gralow, MD, is a well-respected and internationally renowned breast oncologist. In this episode, Gralow discusses her journey in oncology, the ASCO Global Oncology Task Force and the importance of finding your own way in medicine.

Intro :14
About Gralow :27
The interview 1:49
What has been your journey to become the very well-respected internationally renowned breast oncologist you are today? 2:21
How did you find yourself in that aspect of the field and also marry in your interest in mobile oncology? 4:31
Were there times where you faced barriers you weren’t going to be able to overcome? 13:13
How did you feel and what did you think when you led the ASCO Global Oncology Task Force? 16:15
What are some of the high points that came out of the ASCO Global Oncology Task Force report? 19:20
Did you focus on how the COVID-19 pandemic affected oncology management in this task force or in any of your global oncology work? 26:30
Did you find that social media was a useful tool throughout the last 9-10 months navigating the pandemic? 30:11
Realizing the benefits of social media as a medical professional and avoiding “doom scrolling” 34:00
Do you have one pearl for the audience? 41:47
How to find Julie Gralow 43:11
Where does Gralow see her future career going? 44:22

Julie Gralow, MD is the Jill Bennett Endowed professor of Breast Medical Oncology and professor of global health at the University of Washington School of Medicine, professor in the Clinical Research Division at the Fred Hutchinson Cancer Research Center, and director of Breast Medical Oncology at the Seattle Cancer Care Alliance.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Julie Gralow can be reached on Twitter @jrgralow and by email at pink@uw.edu. Follow us on Twitter @HemOncToday @ShikhaJainMD.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Gralow reports no relevant financial disclosures.

View Details

As a resident, Dan Tran, DDS, experienced the unthinkable – he was diagnosed with stage IV lung cancer. In this episode, Tran shares his story – from diagnosis, to undergoing treatment and finishing residency amidst the COVID-19 pandemic.

Intro :04
About Tran :13
The interview 1:59
How did you end up in oral and maxillofacial surgery? 2:06
How were you diagnosed with stage IV lung cancer? 2:52
How did you process your diagnosis? 7:07
Was your program supportive? 8:22
How did you go through surgery? 11:20
When did you start blogging about your experience? 17:10
Do you feel this has changed the way you practice as a physician? 20:50
Has your work/life balance changed significantly? 22:39
How did you balance residency and treatment during COVID-19? 25:49
Have you become more vocal about cancer screening or advocacy topics? 29:59
Where do you see yourself in the next few years? 33:17
What would you want someone to take away from this episode? 35:48
How to reach Tran 36:48

Dan Tran, DDS, is a professor of oral and maxillofacial surgery at Virginia Commonwealth University.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Tran can be reached via email at trandq@vcu.edu or via his blog at www.danfightscancer.com. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Tran reports no relevant financial disclosures.

View Details

Avital Y. O’Glasser, MD, FACP, FHM, is a hospitalist who specializes in perioperative medicine and social media. In this episode, we discuss how perioperative medicine has adapted amid the pandemic, take-homes from the Women in Medicine Summit and the role of social media in health care.

Intro :04
About O’Glasser :13
The interview 1:50
How did you get where you are now? 1:55
Tell us more about perioperative medicine 4:45
How has the pandemic affected perioperative medicine? 9:02
How have you navigated all of these changes? 17:39
What drew you to the Women in Medicine summit, and what did you get out of it? 22:45
Why is it so important to include social media on CVs? 28:08
Women, academic medicine and social media 33:10
Social media has made our world smaller in a good way 38:08
What is the CV matrix? 46:53
O’Glasser’s take-home message 51:56
How to reach Dr. O’Glasser 53:32

Avital Y. O’Glasser, MD, FACP, FHM, a hospitalist and associate professor of medicine within the Division of Hospital Medicine, Department of Medicine at Oregon Health & Science University. She is also medical director of the Preoperative Medicine Clinic and the assistant program director for social media and scholarship for OHSU’s Internal Medicine Residency Program.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. O’Glasser can be reached on Twitter at @aoglasser. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. O’Glasser reports no relevant financial disclosures.

View Details

Pamela Kunz, MD, is an expert in GI cancers and a courageous voice against gender discrimination and harassment in health care. In this episode, Kunz shares her story and provides guidance for those facing these types of challenges.

Intro :04
About Kunz :13
The interview 1:45
How did you get where you are now? 2:04
Can you tell us about your recent transition from Stanford to Yale? 3:40
How did you decide to start speaking out? 6:54
How do you guide women who find themselves in a similar situation? 9:11
What happened after you came out with this information? 11:32
If you don’t witness it, you may not know it’s happening 14:27
What are some of the challenges you encountered after going public? 17:16
Don’t read the comments 18:45
Did you tell Yale this would come out before transitioning from Stanford? 20:43
The importance of having support 22:40
Moving the needle 24:56
At what point should people be reporting these things? 28:58
If no one’s reporting, things won’t change 43:07
The importance of mentors and sponsors 34:24
Do you think this experience has changed you as a leader? 36:21
Kunz’s take-home message 40:48
How to reach Dr. Kunz 42:00

Pamela Kunz, MD, is an associate professor of medicine in the Division of Oncology at Yale University School of Medicine; leader of the Gastrointestinal Cancers Program at Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center; and director of GI Medical Oncology within the Section of Medical Oncology.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Kunz can be reached on Twitter at @PamelaKunzMD and via email at pamela.kunz@yale.edu. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Kunz reports stock and other ownership interests in Guardant Health; consulting or advisory roles with Advanced Accelerator Applications, Ipsen, Lexicon and Novartis; and research funding from Advanced Accelerator Applications, Brahms (Thermo Fisher Scientific), Ipsen, Lexicon and Xencor.

View Details

Editor’s Note: This episode was recorded prior to President Donald J. Trump testing positive for COVID-19.

In this episode, Arghavan Salles, MD, PhD, explains the concept of stereotype threat, shares how she became interested in gender equity work and details her experience on the frontlines of COVID-19.

Intro :04
About Salles :13
The interview 1:11
How did you end up where you are now? 1:28
What led you to start doing more work in gender equity? 4:53
Stereotype threat and lack of opportunity 9:00
Have you faced a lot of negativity in this space? 12:04
Stepping outside of your comfort zone 19:10
How did you decide to work in COVID-19 hot spots? What was it like? 22:55
Masks have become politicized 37:50
What’s the path forward? 42:22
Have you been active in voting/politics? 46:29
Thank you for everything you do 48:14
Salles’ take-home message 48:38
How to find Salles 49:55

Arghavan Salles, MD, PhD, is a minimally invasive and bariatric surgeon. She is a Scholar in Residence within the Educational Programs and Services at Stanford University School of Medicine.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Salles can be reached on Twitter at @arghavan_salles and on Instagram at @arghavansallesmd. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Salles reports she is a consultant for Intuitive Surgical and Intuitive Foundation.

View Details

In this episode, Darilyn Moyer, MD, FACP, FRCP, FIDSA, shares how she overcame imposter syndrome to get to where she is today, and how she hopes the pandemic could systemically help right the wrongs currently faced by women and underrepresented groups in medicine.

Intro :04
About Moyer :13
The interview 3:44
How did you get where you are now? 3:53
How did you get over your imposter syndrome? 9:12
“We cannot be what we cannot see” 11:15
Tell me about the jedi mindset; what’s the initiative and what does it mean to you? 11:48
Are you optimistic that we’re heading in the right direction? 17:39
The pandemic has shed light on inequities 19:37
With your background in ID, what are your thoughts on the pandemic? 25:45
“Medicine is an art and a science” 32:44
This being an election year, what’s your advice for voting? 37:12
Thank you for everything you and the ACP do 43:02
Moyer’s take-home message 44:00
How to find Moyer 45:27

Darilyn V. Moyer, MD, FACP, FRCP, FIDSA, is adjunct clinical professor of medicine at Lewis Katz School of Medicine at Temple University, and executive vice president and chief executive officer of American College of Physicians.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Moyer can be reached on Twitter at @DarilynMoyer and via email at dmoyer@acponline.org. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Moyer reports no relevant financial disclosures.

View Details

Don Dizon, MD, is an innovator in oncology and an expert in social media. In this episode, we discuss the importance of authenticity and how platforms like Tik Tok have helped him engage with patients.

Intro :04
About Dizon :17
The interview 1:29
How did you get to where you are from your beginnings? 1:39
How were you able to navigate around the ideology of sub-subspecializing and do all of this exciting and innovative stuff? 5:45
The importance of giving support to faculty members in trying new innovations 10:20
How has your social media life been viewed? How did you become this social media expert and have that be accepted, even lauded by the people you work with? 12:09
How does your social media presence and content provide accessible information to patients while showing a human side? 18:35
How and why did you choose the platforms you engage on? 20:38
How do you come up with content for your TikTok videos? 23:11
What types of things have you done academically that have helped your career and the academic world? 27:55
What are some other pitfalls you’ve noticed with social media? 34:30
If people are interested in doing something off the beaten path … where can they go to get guidance and help? 40:41
Dizon’s one pearl 45:22
How to find Dizon 45:51

Don Dizon, MD, is a professor of medicine at Brown University and is a medical oncologist specializing in the care of women with breast or gynecologic cancers, survivorship, particularly as it pertains to sexual health for men and women with cancer, patient engagement and social media. He also serves as the director of men’s cancers and director of hematology/oncology clinics at Lifespan Cancer Institute in Rhode Island.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Dizon can be reached on Twitter, Instagram and TikTok at @drdonsdizon. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Healio was unable to confirm relevant financial disclosures for Dizon at the time of posting.

View Details

In this episode, Pat Basu, MD, MBA, president and CEO of Cancer Treatment Centers of America, sits down with me to discuss the effects misinformation and “false choices” have on patients and science, and how to find middle ground in these uncertain times.

Intro :04
About Basu :16
The interview 3:45
How did you get to where you are today? 3:46
The importance of compartmentalizing roles in life 6:37
Basu’s role at the White House 7:32
How do you feel things have been going regarding the pandemic? Where were the breakdowns in communication? 12:27
How the pandemic has led to misinformation for patients and the politicizing of science 16:35
How critical thinking and the search for accurate information is being muddled 21:12
Basu’s feeling on “false choices” 25:30
Policy inconsistencies during the pandemic 29:19
Unintended consequences 33:00
Basu’s explanation of the “shadow curve” in relation to COVID-19’s impact on cancer and other chronic illnesses 35:32
Are you optimistic that things are going to improve in the next several years? 41:40
The importance of health care systems changing with the times 43:47
Basu’s one pearl 46:30
How to find Basu 47:38

Pat Basu, MD, MBA, is the president and chief executive officer of Cancer Treatment Centers of America Global, Inc., which includes the Cancer Treatment Centers of America Comprehensive Cancer Care Network of hospitals and Outpatient Care Centers and serves as a member of the national Board of Directors at CTCA. Basu is also a recipient of the American Medical Association’s National Excellence Award for Leadership, the Crain’s Chicago Business 40 Under 40 Award, Stanford Medicine’s Physician of the Year Award, University of Illinois Distinguished Alumni Award and the University of Chicago Booth School of Business’ Distinguished Alumni Award.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Basu can be reached at pat.basu@ctca-health.com and on Twitter at @patbasu. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Basu is the president and CEO of Cancer Treatment Centers of America.

View Details

In this episode, Benjamin O. Anderson, MD, FACS, creator and chair of The Breast Health Global Initiative at Fred Hutchinson Cancer Research Center and Consultant for Cancer Control to the WHO, shares how his passion for patient care dovetailed into a career in global oncology.

Intro :14
About Anderson :20
The interview 2:16
How did you end up in breast cancer care and how did it evolve into global oncology? 2:27
How do you utilize these criteria and protocols and tailor it to each of the countries that come with their own challenges? 11:39
Jain on the importance of global medicine 16:39
Where have you found that implementation of this has been most successful so far? 22:44
Have you seen these protocols used for treating other cancers? 25:50
Have you seen, through your global health work, any cool innovations that have come out of unique situations? 30:57
Going to all these different institutes in different countries, have you found anything that you thought was really amazing and that should be brought stateside? 37:10
Anecdote on the need to find better ways to documentation for billing and its relation to physician burnout 42:10
Jain anecdote on the need for a healthy balance to reduce risk for burnout 45:30
Anecdote on the importance of physicians taking on leadership/government roles 49:20
Have you seen a major change in health care delivery or global oncology navigating through the pandemic? 52:40
Anderson’s one pearl 56:40
How to find Anderson 57:00

Benjamin O. Anderson, MD, FACS, is professor of surgery and global health medicine at the University of Washington, chair and director of The Breast Health Global Initiative at Fred Hutchinson Cancer Research Center, and consultant for cancer control to the WHO.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Anderson can be reached at bhgi.org. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Healio was unable to confirm Anderson’s relevant financial disclosures at the time of posting.

View Details

We are in an election year, and as we continue to navigate a pandemic, exercising the right to vote is more important than ever. In this episode, I speak with the founders of the nonpartisan initiatives VoteHealth2020, and the Womxn Vote 100 initiative.

Intro :14
About Sharma :54
About Pammal 1:23
How did Sharma get to where she is today? 2:20
How did Pammal find herself being active in the health care strategy and health care initiatives world? 5:02
What is VoteHealth2020? 8:20
Pammal on VoteHealth 2020 and where she hopes to see it go 10:45
What types of things are you initiating and what types of plans do you have to make health care an important part of the dialogue in this election? 12:18
Do you feel that the tide has changed and that physicians are now more comfortable being “political?” 17:09
Anecdote on the importance of dialogues with patients about being active in the political process 20:05
About the Womxn Vote 100 initiative 26:45
Are there certain metrics that you hope to aim for with the initiative? 32:45
Sharma on being able to educate patients on how to vote safely during the pandemic 35:55
Pammal’s one pearl 41:40
Sharma’s one pearl 42:03
How to find VoteHealth 2020 43:23

Manisha Sharma, MD, FAAFP, is a board-certified family medicine physician, who works at the juncture of patient care, social justice, health policy, and innovation. She has organized and led numerous grassroots physician campaigns through the organization Doctors for America where she served as the National Director of Leadership Cultivation. She is a current Leadership Fellow at the California Health Care Foundation. She is a co-founder of VoteHealth 2020.

Shalini Pammal, MSPH, is a creative strategist, movement builder and health advocate. She focuses on the intersection between health policy, health care delivery and financing for payer, provider, systems and services clients at the Boston Consulting Group. She is a co-founder of VoteHealth 2020.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Sharma and Pammal can be reached at votehealth2020.com and on Twitter at @votehealth2020. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Pammal and Sharma are the founders of VoteHealth 2020.

View Details

In this episode, Sasha K. Shillcutt, MD, MS, FASE, cardiac anesthesiologist, published author and founder of Brave Enough, discusses the importance of finding our authentic selves, inspiring change and caring for each other in medicine.

Intro :14
About Shillcutt :27
The Interview 2:30
How did you get to where you are today? 3:30
What is your typical day like clinically? 10:51
The importance of self-care as doctors 13:34
The importance of connecting with and humanizing fellow physicians 19:25
How did you decide to be a cardiac anesthesiologist when it’s predominately a male-dominated field? 24:42
How have you managed to merge all the aspects of your life and career? 31:39
Anecdote on the need for innovative ways of thinking in the people who work in health care 37:48
Shillcutt on the importance of establishing relationships and allies 39:39
Why Shillcutt chose to write a book with everything else she has going on in her career and life 41:39
How to find Shillcutt and her book 46:40

Sasha K. Shillcutt, MD, MS, FASE is a tenured professor and the vice chair of strategy and innovation in the department of anesthesiology at the University of Nebraska Medical Center. She is also the CEO and founder of Brave Enough, a well-published researcher in cardiac anesthesiology and gender equity; cardiac anesthesiologist, published author and international speaker.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Shillcutt can be reached at her website becomebraveenough.com and on Twitter at @rubraveenough. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Shillcutt is founder/owner of Brave Enough LLC, a website and blog for professional women.

View Details

Narjust Duma, MD, is a thoracic oncologist, gender equity warrior and social media phenomenon. In this episode, we discuss recent events, microaggressions against women and people of color, and the beauty of diversity.

Intro :14
About Duma :18
Jain’s history with Duma 2:08
The interview 3:09
How did you start getting into this specific work where you started doing research looking at the gender disparities that exist in oncology? 6:09
Jain anecdote on conforming to gender standards that changed her personality 10:17
Microaggression against women in power in the workplace and gender-based language 16:45
Duma’s anecdote about cheese and the beauty of diversity 22:15
Journal of Vascular Surgery’s controversial article on professional behavior 24:12
Patients want their doctors to be human beings, not robots 29:40
Duma’s thoughts on the #MedBikini movement, gender equity and intersectionality 31:50
Duma on minority women being reluctantly volunteered to fix issues with gender inequalities and ethnic and racial inequalities 35:28
Duma anecdote on the importance of the bystander effect on treating microaggressions 39:10
The importance of positive feedback and giving of self for others 41:50
Anecdotes on food and how it equates to living life 45:10
Duma on using your challenges and discouragements to fuel your motivation 49:01
Duma’s pearls 52:48
How to find Duma 53:18

Narjust Duma, MD, is an assistant professor and thoracic oncologist at the University of Wisconsin’s School of Medicine and Public Health and the co-founder of Latinas in Medicine.

References:

Hardouin S, et al. J Vasc Surg. 2020;72:667-671.

Chimamanda Ngozi Adichie: We should all be feminists. https://www.ted.com/talks/chimamanda_ngozi_adichie_we_should_all_be_feminists?language=en. Dec. 2012.

House AOC Recording - AOC Final. https://cdn.jwplayer.com/players/9yPHdik6-HWSueGzu.html. July 23, 2020. (Note: The video includes profanity).

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Narjust Duma can be reached at @NarjustDumaMD. Follow us on Twitter @HemOncToday @ShikhaJainMD

Disclosures: Duma reports consulting for AstraZeneca and Inivata, Inc. Jain reports she is a paid freelance writer for Lippincott.

View Details

My long-time friend Mark Loehrke, MD, FACP, recently celebrated his 32nd year in academic medicine; to say he has a passion for teaching internal medicine is an understatement. In this episode, we discuss the importance of mentorship and the impact of COVID-19 on education, and Loehrke shares a phrase that’s motivated him throughout his career.

Intro :14
About Loehrke :25
Jain’s history with Loehrke 2:34
The interview 3:35
How did you find yourself drawn to medical education? 4:22
Loehrke’s anecdote on the conversation that changed the course of his career 8:50
The importance of building good relationships between mentor and mentee 16:45
Have you found that’s a challenge — talking to other people who are either trying to find mentors or trying to find mentees, or trying to establish these relationships? 20:25
Bridging the generational gap between mentor and mentees 23:35
How have things changed for you as an educator during the COVID-19 pandemic, and how are you helping students navigate this very odd time that we’re in? 29:33
I know you do color-coordinated rounds. Can you explain what that is and how did you modify that? 33:55
Do you think there’s anything positive that’s come out of this pandemic in terms of medical education or anything related to medicine? 36:08
Trying to find optimism during the pandemic 39:10
Anecdotes on Loehrke’s height 40:59
Loehrke’s one pearl 44:09
How to find Loehrke 46:29

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Mark Loehrke can be reached at mark.loehrke@med.wmich.edu. Follow us on Twitter @HemOncToday @ShikhaJainMD

Mark Loehrke, MD, is an associate professor and chair of the department of medicine at Western Michigan University’s Homer Stryker School of Medicine.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Loehrke reports no relevant financial disclosures.

View Details

Kikkan “Kikkanimal” Randall is an Olympic champion, active mom, cancer fighter and “Get-Activist.” In this episode, she shares how her positive attitude and athlete mentality have helped her navigate a breast cancer diagnosis and treatment, and she shares valuable advice for both oncologists and patients.

Intro :14
About Randall :17
The interview 1:56
Tell us a bit about you. Who are you? How did you get to where you are and how did you decide you wanted to be a part of the U.S. Olympic cross-country ski team? 2:18
How were you diagnosed? 4:44
How old were you when you first realized that you had this pebble in your breast? 6:00
What type of mentality is it that makes you such a phenomenal Olympic athlete that you were able to translate into this taking charge of your health and taking charge of your cancer as you move forward? 7:54
What was the best way for you to cope as you felt this loss of control going through your treatment in certain times? 10:40
What did you do to prepare for your clinic visits when you were trying to advocate for yourself? 14:53
How did you navigate the disease with your son? 20:10
How long do they recommend for you to wait to try again (to conceive)? Did you have those conversations? 23:40
Do you feel like you are mentally approaching this period of your post-cancer care or your post-treatment time? 27:22
Randall running a marathon following the completion of her treatment 31:40
How did you get involved with Healthy Futures and Fast and Female, and what exactly do they do? 35:15
Did the way that you participate in advocacy change after you were diagnosed with cancer? 40:02
One thing you wish oncologists knew when they are treating patients with any kind of cancer, and one thing patients should know if they’re newly diagnosed? 45:40
How to find Randall 47:39

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Kikkan Randall can be reached at kikkan.com. Follow us on Twitter @HemOncToday @ShikhaJainMD

Kikkan Randall is an Olympic champion, active mom, cancer fighter and “Get-Activist.”

Disclosures: Jain reports she is a paid freelance writer for Lippincott.

View Details

In this episode, I speak with Eric Reinhart, an MD-PhD candidate at the department of anthropology at Harvard and University of Chicago Pritzker School of Medicine. He is also a candidate in adult psychoanalysis at The Chicago Center for Psychoanalysis. We discuss the impacts of jail cycling on the COVID-19 pandemic, and future directions for reform in our health care system.

Intro :14
About Reinhart :17
The interview 1:44
What led to your journey as an MD-PhD candidate? 2:12
When you first started this study, what were you trying to look at and what did you end up finding during your research? 4:54
The point was to look at the individuals who were put in jail and were awaiting trial or awaiting a decision as to whether they were going to go to prison or not. And that was the population you focused on, is that correct? 8:25
What were you feeling as you watched the protests the last couple of months? 9:44
What were the major points that your study found? 11:53
What types of controversy have you experienced, and have you addressed that in the last couple of months? 18:15
What types of studies are you hoping to be able to do moving forward? 24:28
Can you expand on how to address racial disparities and systemic issues in jailing? 30:46
The need for solutions and to implement them as well as how to ensure change among physicians 39:00
Do you have one pearl for the audience? 44:27
How to find Eric Reinhart 45:52

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Eric Reinhart can be reached at reinhar@fas.harvard.edu. Follow us on Twitter @HemOncToday @ShikhaJainMD

Eric Reinhart is a PhD candidate in the department of anthropology at Harvard University, and an MD candidate at the University of Chicago Pritzker School of Medicine. He is also a candidate in adult psychoanalysis at the Chicago Center for Psychoanalysis.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Reinhart reports no relevant financial disclosures.

View Details

Dana Corriel, MD, is a board-certified internist, an entrepreneur, and the founder of SoMeDocs, also known as Doctors on Social Media. She has created a platform that has helped launch, amplify and connect many physicians in the social media space. In this episode, we explore why social media is so important in today's health care landscape, and share some tips on how to get your feet wet in the space.

Intro :13

About Dr. Corriel :17

The interview 2:30

Where did the idea for SoMeDocs come from? 2:50

What are some of the challenges you’ve faced? 4:07

When you first thought of this concept, what was your goal? 5:28

Why do you think social media is so important to incorporate into health care? 9:04

Do you think more people have turned to social media during the pandemic? 10:34

What do you say to the people who feel social media isn’t for them? 16:50

Can you give examples of how #medtwitter has been harsh? 20:53

How do you navigate that? 23:01

Anecdotes 25:16

When you talk to physicians apprehensive of joining social media, what are positives they’ll gain? 27:58

People may not know how to use social media to their benefit 31:43

How do you determine whether to share your family on social media? 34:49

Do you have one pearl for the audience? 37:45

How can people find you? 38:46

We’d love to hear from you! Send your comments/questions to oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD @drcorriel @SoMeDocs

Dana Corriel, MD, is a board certified internist and founder of SoMeDocs (Doctors on Social Media), an online platform where physicians can network, build online presence effectively, and grow their accounts in order to meet their end goals.

Disclosures: Corriel is owner of SoMeDocs. Jain reports she is a paid freelance writer for Lippincott.

View Details

As the director of The University of Arizona Cancer Center's Clinical Trials Office, and national expert in pancreatic and biliary cancers, Rachna Shroff, MD, shares the impact COVID-19 has had on our patients, clinical trials, and cancer care.

Intro :13

About Dr. Shroff :21

The interview 1:45

How did you end up in GI medical oncology? 1:52

You’ve become a nationally known leader in the biliary space 4:45

How has your clinical practice changed, and how has clinical trial enrollment changed since COVID-19? 6:08

Many clinical trial modifications occurred so quickly; how do you think that was possible? 14:10

What has changed the most for you since COVID-19 began? 10:38

Things have been moving quickly to be more nimble than usual 16:23

Are you concerned about the impact this will have on our patients after the acuity of COVID-19? 17:50

Do you think we’ll see flexibility in treatment plans going forward? 20:42

Do you think clinical trials will be able to incorporate telehealth for check-ins? 22:30

What are your thoughts on how trials/studies/data have been presented about COVID-19 in general? 28:05

How do you help people navigate the data? 31:14

What are you optimistic about for the future? 35:54

How to get in touch with Dr. Shroff 39:23

We’d love to hear from you! Send your comments/questions to oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD @rachnatshroff

Rachna T. Shroff, MD, MS, is an associate professor in the division of hematology and oncology; chief of the Section of GI Medical Oncology; leader of the GI Disease-Oriented Team; and director of the Clinical Trials Office at The University of Arizona Cancer Center.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Shroff reports she has received research funding from Exelixis, Halozyme, Merck, Pieris and Taiho, and has served as an advisory board member for Agios, Clovis Oncology, Debiopharm, Exelixis, Merck, QED Therapeutics and Seattle Genetics.

View Details

As the interim chief of her division, associate director for medical affairs and chief medical officer for cancer services, Merry J. Markham, MD, FACP, FASCO, has extensive leadership experience. In this episode, we explore how her leadership style has evolved throughout this pandemic, and end with some pearls of wisdom on effectively utilizing social media in health care.

Intro :13

About Dr. Markham :17

The interview 1:39

How did your journey lead you to Florida and as interim chief? 1:43

It speaks to the community and culture of an institution if people are staying 4:20

How do your roles differ, and how are they intertwined? 4:56

Continuing to see patients helps be a good leader 9:26

What has changed the most for you since COVID-19 began? 10:38

It’s impressive how quickly things can be implemented when there’s a pandemic 13:34

How did you pivot from leading to leading in crisis mode? 16:15

You can find Dr. Markham’s COVID-19 blog on cancer.net 22:42

Any examples of poor leadership? 23:10

How did you get started in social media in health care? 25:50

Have you been able to utilize social media to advance your career? 29:34

Have you had people tell you it’s a waste of time? 33:28

Do you have advice for people who want to get started on social media? 39:44

How can leaders utilize social media? 42:57

Final thoughts 44:45

How to find Dr. Markham online 46:12

We’d love to hear from you! Send your comments/questions to oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD @DrMarkham

Merry J. Markham, MD, FACP, FASCO, is interim chief of the division of hematology and oncology and an associate professor in the division of medicine at University of Florida Health. She is also associate director for medical affairs for the UF Health Cancer Center and chief medical officer for cancer services.

Disclosures: Jain reports she is a paid freelance writer for Lippincott.

View Details

Garth Walker, MD, MPH, is an emergency room physician in Chicago, the chief medical officer and head of innovation for Clinify Inc., and the chief equity officer of Illinois Medical Professionals Action Collaborative Team, also known as IMPACT. In this episode, we discuss the two public health crises currently facing the nation, structural racism and its impact on health care, and a path forward.

Intro :13

About Dr. Walker :18

The interview 2:35

How did you become an ER physician and involved in so many initiatives? 2:45

Are you on a path you foresaw for yourself as a child? 8:28

How are you helping patients and friends navigate the intersection of two public health crises? 11:23

Some people don’t take a stand unless they feel it directly effects them 20:12

Why do you think the death of George Floyd has led to such unification? 23:00

How much of this do you think is happening without being reported? 28:50

Are you starting to see changes you think might lead to future structural changes? 32:18

How can people be allies without it seeming like lip service? 41:15

I’m hopeful that we’ll come out of this stronger and more unified 44:31

What are your takeaways? 49:21

How to find Dr. Walker on social media 51:32

We’d love to hear from you! Send your comments/questions to oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD @garthwalkermd

Garth Walker, MD, is an emergency medicine specialist, researcher, and innovator in Chicago with academic, non-profit, and private sector experience in both start-ups and impact investing. He is an attending physician at the Jesse Brown Veteran Affairs Hospital and an health equity fellow with the Northwestern Emergency Department and Northwestern Buehler Center for health economics and policy. He is also a co-founder, chief medical officer and head of innovation for Clinify Inc.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Walker reports he has equity in Clinify Inc.

View Details

In this episode, award-winning author and nationally renowned journalist Michele Weldon shares tips on how to use your voice to amplify your message. Whether through writing, public speaking or social media, getting your voice out there is important; in this episode, Weldon gives tips and tricks on how to do so effectively.

Intro :13

About Michele Weldon :15

The interview 3:18

Why should folks in health care amplify their voices? 3:22

What is an effective way for people to get their voices out in nonacademic mediums? 4:32

How do you talk to people who may be hesitant to add their voice? 6:22

How can we encourage more people to use their voices? 11:34

How do you get started writing? 13:58

How do you pivot from writing an op-ed to writing a book? 18:21

Why write a book? 21:28

How have you been able to incorporate your life into your books? 23:17

What are three tips for someone who wants to get into writing? 31:51

What’s the best way to get started with public speaking? 36:30

Scripts are important, but practice is key 42:18

Are coaches useful? 44:33

What are your takeaways? 50:32

How can people find you on social media, and how can they buy your book? 53:02

We’d love to hear from you! Send your comments/questions to oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD @micheleweldon

Michele Weldon is an award-winning author, journalist and emerita faculty in journalism at Northwestern University, where she taught on the undergraduate and graduate levels for 18 years. She is the author of six nonfiction books, including the upcoming “Act Like You’re Having A Good Time.”

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Weldon reports no relevant financial disclosures.

View Details

Vinay Prasad, MD, MPH, an academic oncologist and host of the podcast Plenary Session, shares insight on his recently published book Malignant, his thoughts on the unsustainability of the current state of oncology, and provides guidance on how to navigate modern day oncology and the complexities of constantly evolving cancer care.

Intro :13

About Dr. Prasad :17

The interview 1:20

How did you get here? 2:05

How to stay out of hot water 5:28

How do you navigate everything? 8:38

How can others navigate through all of the information? 13:32

What is important from the first section of your book? 16:42

Dealing with cost questions 21:22

The impact of social media on health care and cancer care 23:51

The distinction between precision oncology and personalized care 30:16

What are your biggest takeaways from the last section of your book? 34:21

What are your hopes for cancer care? 37:59

What’s next for you? 43:20

Final thoughts from Dr. Prasad 46:02

How to find Dr. Prasad on social media and buy his book 48:05

We’d love to hear from you! Send your comments/questions to oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD @VPrasadMDMPH

Vinay Prasad, MD, MPH, is a practicing hematologist-oncologist and associate professor of medicine at the University of California San Francisco. He studies cancer drugs, health policy and evidence-based medicine. He is author of over 200 academic articles, and the books Ending Medical Reversal (2015), and Malignant (2020). He hosts the oncology podcast Plenary Session.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Prasad reports receiving research funding from Arnold Ventures; royalties from Johns Hopkins Press and Medscape; honoraria for grand rounds/lectures from universities, medical centers, nonprofits and professional societies; consulting from UnitedHealtcare; and speaking fees from Evicore. He reports his podcast Plenary Session has Patreon backers.

View Details

Mark Shapiro, MD, host of Explore the Space podcast joins us to discuss the role of social media in health care, the evolving role of physicians as public voices and figures, and the evolution of health care through this COVID19 pandemic.

Intro :13

About Dr. Shapiro :14

The interview 1:20

In this episode 1:34

How did you become active on social media as a physician? 2:09

What has changed in social media since COVID-19? 4:39

Do you think the way we address politically charged topics has changed as more physicians become active on social media? 6:28

When physicians are scared to get online, how do you address that? 9:03

How have you evolved in this role? 11:56

The great thing about social media is you can feel supported by people you’ve never met 14:28

How do we identify the experts we should be listening to during COVID-19? 18:36

How has the practice of medicine change since the pandemic started? 25:27

Sustaining ourselves and our teams is important 29:30

How do you think COVID-19 will change our health care system? 31:22

Do you have any ideas on how we can use the past to improve our future? 33:18

Do you have any thoughts on how/if COVID-19 will impact discussions on climate change? 36:55

Final thoughts and where to find Dr. Shapiro on social media 40:35

We’d love to hear from you! Send your comments/questions to oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD @ETSshow

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Shapiro reports no relevant financial disclosures.

View Details

The COVID-19 pandemic continues to affect the lives of individuals from across the globe. In this episode, Kelly Cawcutt, MD, an assistant professor of medicine and board-certified infectious disease and critical care physician at the University of Nebraska Medical Center, shares her expertise on the ongoing pandemic and its impact on health care.

We’d love to hear from you! Send your comments/questions to oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD @KellyCawcuttMD

Disclosures: Cawcutt reports no relevant financial disclosures. Jain reports she is a paid freelance writer for Lippincott.

Oncology Overdrive: Recent Episodes

Shikha Jain, MD